• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Infectious Diseases Society of America (IDSA): IDWeek 2013
 

Infectious Diseases Society of America (IDSA): IDWeek 2013

on

  • 1,275 views

 

Statistics

Views

Total Views
1,275
Views on SlideShare
1,270
Embed Views
5

Actions

Likes
0
Downloads
3
Comments
0

1 Embed 5

http://www.mdconferencefinder.com 5

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Infectious Diseases Society of America (IDSA): IDWeek 2013 Infectious Diseases Society of America (IDSA): IDWeek 2013 Document Transcript

    • SanFrancisco October 2-6, 2013 www.IDWeek.org PRELIMINARY PROGRAM
    • IDWEEK 2013TM visit: www.idweek.org2 The IDWeek Partners wish to extend a special Thank You to the following organizations who developed sessions in collaboration with the IDWeek Program Committee. American Academy of Pediatrics American Sexually Transmitted Diseases Association American Society of Tropical Medicine and Hygiene British Columbia Centre for Disease Control Center for Global Health Policy European Centre for Disease Prevention and Control European Society of Clinical Microbiology and Infectious Diseases International Immuncompromised Host Society International Society for Heart and Lung Transplantation National Institute of Allergy and Infectious Diseases National Network of STD/HIV Prevention Training Centers Society of Infectious Diseases Pharmacists Wake Forest University School of Medicine A listing of specific sessions these organizations have contributed is located under Allied Societies on pages 39-40. Acknowledgements
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org3 Schedule-at-a-Glance....................................................................................................... 4 IDWeek Program Tracks.................................................................................................. 6 Pre-meeting Workshops.................................................................................................. 13 Official IDWeek Program Sessions................................................................................. 15 Allied Societies............................................................................................................... 39 IDWeek 2013 Program Committee............................................................................... 41 Table of Contents
    • Schedule-at-a-Glance IDWeek is the scientific meeting for each partner organization (IDSA, SHEA, HIVMA, and PIDS). visit: www.idweek.org4 PRE-MEETING WORKSHPS (additional fees apply) Tuesday, October 1, 2013 8 a.m. – 5 p.m.   w Best Practices in Antimicrobial Stewardship Programs w Vincent T. Andriole ID Board Review Course 1 – 5 p.m. w IDSA Maintenance of Certification Workshop: Self-Evaluation of Medical Knowledge Modules: General Infectious Diseases 2011 (Updated February 2013), Infections in the Non-HIV Immunocompromised Host Wednesday, October 2, 2013 8 a.m. – Noon       w Fellows’ Day Workshop w HCV Treatment Options: Opportunities for the ID Practice w IDSA Maintenance of Certification: Self-Evaluation of Medical Knowledge Modules: HIV 2013 and Hepatitis C w Pediatric Fellows’ Day Workshop w TB Workshop IDWEEK MEETING SESSIONS Wednesday, October 2, 2013 1:30 – 3:30 p.m.             INTERACTIVE SESSION w Challenging Cases in Pediatric Infectious Diseases SYMPOSIA w Combination Therapy to Combat Antimicrobial Resistance and Optimize Therapy w Influenza w New Insights into the Microbiology and Epidemiology of Multidrug-Resistant Gram-Negative Bacteria w Payment Reform as the Driver for Healthcare Reform w Prevention of Healthcare-Associated Infections:The Worldwide Perspective w What’s Hot in ID and HIV 3:45 – 5:45 p.m. SPECIAL PLENARY SESSION: Emerging Infections w Jeremy Farrar, BSc, MBBS, FRCP, DPhil; Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam w Richard Besser, MD; ABC News, NewYork, NY Thursday, October 3, 2013 7 – 8:15 a.m. MINI-SYMPOSIUM w GRADE-ing the Guideline Development Process MEET-THE-PROFESSOR SESSIONS w Antimicrobial Use and Stewardship in Neonatal ICUs w Early Success and Challenges in Ventilator-Associated Event Reporting to NHSN w Outpatient Antibiotic Therapy to Address Preventable Hospitalizations w Power Hour: New Requirements for ABIM MOC in 2014;What ID Physicians Need to Know w Rapid Diagnostics for Infection Prevention and Antimicrobial Stewardship 7 – 8:15 a.m. w Red Book Updates w Top 10 Papers in Transplant Infectious Disease w Travel Medicine for Adults and Children w Update on HIV-Related Guidelines 8:30 – 10 a.m.             INTERACTIVE SESSION w Clinical Controversies SYMPOSIA w Advances in the Prevention of HAIs in Children w Human Papillomavirus w Immunosenescence and Infectious Disease w Meaningful Antimicrobial Stewardship Outcomes w Preventing Infection in Healthcare Personnel w Update on Fungal Diagnostics 8:30 a.m. – 3:30 p.m. SYMPOSIUM w A Reinterpretation of Borders: Lessons Learned from Mycobacterium tuberculosis Pathogenesis 10:30 a.m. – Noon             INTERACTIVE SESSION w HIV Interactive SYMPOSIA w Genomic Tools for Personalized Infectious Diseases Management and Outbreak Investigations w Infections in the Aged:The What, Why, and How w Infectious Complications of Immunomodulating Biologic Agents w Polio Eradication w Relapsing Clostridium difficile Infection (CDI):When Standard Medical Therapy Fails w The Environment—A New Frontier 2 – 3:30 p.m.           INTERACTIVE SESSION w New IDSA Guideline: Laboratory Diagnosis of Infectious Diseases SYMPOSIA w Advances in HIV Prevention w Global Viral Threats w Media, Social Media, and Open Access: Communicating the Science of Infectious Disease w New Directions for Preventing Surgical Site Infections w Pertussis 3:45 – 5:45 p.m. NAMED LECTURES w John F. Enders Lecture Nancy Cox, PhD; Centers for Disease Control and Prevention, Atlanta, GA w Edward H. Kass Lecture Peter Hotez, MD, PhD; Baylor College of Medicine, Houston, TX SYMPOSIUM w Translating the Science of MRSA Transmission to Practice *Titles, dates, and times are subject to change.
    • visit: www.idweek.org5 Friday, October 4, 2013 7 – 8:15 a.m. MINI-SYMPOSIUM w Antimicrobial Stewardship Innovations: New Ideas Across the Country MEET-THE-PROFESSOR SESSIONS w A Users’ Guide to Microbiome Analysis w Changes in SSI Reporting in 2014 and 2015, Implications and Practice Change w HIV Resistance Testing w Infectious Complications of Mechanical Circulatory Support Devices w Management of Severe Viral Respiratory Infections w Pet-Associated Infections and Zoonoses w Preventing Infections Due to Multidrug-Resistant Gram-Negative Rods: Practical Strategies for Acute and Long-Term Care Facilities w Recognizing Signs and Symptoms of Infection Transmitted Through Transfusion and Transplantation w Wound Care 101 8:30 – 10 a.m.           INTERACTIVE SESSION w Thorny Issues in Infection Control SYMPOSIA w Emerging Infections in Children w HIV State-of-the-Art w Hot Tropical Topics w Infectious Diseases Diagnostics Update 2013 w New Insights into the Epidemiology and Prevention of Clostridium difficile Infection 10:30 a.m. – Noon           INTERACTIVE SESSION w Challenging Cases in Tropical Medicine SYMPOSIA w Integrating Primary and HIV Care in Special Populations w Lessons Learned from Fungal Infections Introduced from the Environment: Epidural Steroid Injections or Natural Disasters w Management and Prevention of Antibiotic-Resistant Infections in Children w Transatlantic Milestones in Infection Control:Where are the European Union and the United States Now? w Vaccines Against Herpes Virus 2 – 3:30 p.m.           INTERACTIVE SESSION w Susceptibility Breakpoints: Controversies, Challenges, and Changes SYMPOSIA w Decolonization for MDRO Transmission Prevention:Who, What, Where, Why? w Hepatitis C and the Infectious Diseases Community w Managing Non-ID Co-Morbidities in HIV-Infected Patients w Pediatric Transplant ID w Uncommon Presentations of Common Diseases 3:45 – 5:45 p.m.     SHEA LECTURESHIP +Top Epidemiology and Infection Control Papers of theYear Denise Cardo, MD, FIDSA, FSHEA; Centers for Disease Control and Prevention, Atlanta, GA SYMPOSIA w Chagas Disease: Diagnosis, Transfusion, Management, Transplantation w Clinical Challenges in the Management of STD: Interactive Cases and Panel for the ID and HIV Specialist w Hot Topics in Pediatric Infectious Diseases 5:45 – 7 p.m. SOCIETY MEETINGS w IDSA, SHEA, HIVMA, and PIDS: Individual Society Meetings/ Receptions Saturday, October 5, 2013 7 – 8:15 a.m.                   MINI-SYMPOSIUM w Antimicrobial Pharmacodynamics in Clinical Practice MEET-THE-PROFESSOR SESSIONS w Diagnosis of Infection in Transplant Recipients w Guidance for Healthcare-Associated Infection Surveillance in Nursing Homes w Infection Prevention and Control During Care of Children and Adults with Cystic Fibrosis w Infections in Pregnancy and their Prevention w Kawasaki Disease:Where are We Now? w Leveraging Technology in ID Clinical Care w Sinus and Ocular Fungal Infections w The ID Physician Who is New to Infection Prevention w Virulence Mechanisms as Antimicrobial Targets: Opportunities and Challenges 8:30 – 10 a.m.             INTERACTIVE SESSION w Interactive Cases in Transplant ID SYMPOSIA w Big Beasts of Infectious Disease w Complex Medical Management in HIV Care w Fungi and the Microbiome w New and Near Available Anti-Infective Therapy w Pneumococcal Disease and Prevention w Vancomycin-Resistant Enterococcus 10:30 a.m. – Noon           SYMPOSIA w Advanced Design and Analysis of Intervention Studies for HAI Prevention w Clostridium difficile Infection in Children w Hot Topics in STIs w Management of the HIV-Transplant Patient w Should Hospital HAI Prevention Policies Translate to Nursing Homes? w Update on Emerging Vector-Borne Diseases in the United States 2 – 3:30 p.m.               INTERACTIVE SESSION w Challenging Cases in ID SYMPOSIA w Biofilm Biology in Infectious Diseases w Choosing a Career in Infectious Diseases w Developments in Diagnostics and Treatment for Tuberculosis w Hand Hygiene—Keeping Hands Clean w Healthcare Reform and the Future of HIV Care w Infection Prevention Beyond Hospital Walls w New Developments in Tuberculosis 3:45 – 5:45 p.m. NAMED LECTURES w Joseph E. Smadel Lecture Myron Cohen, MD, FIDSA; University of North Carolina, Chapel Hill, NC w Maxwell Finland Lecture Victoria Fraser, MD, FIDSA, FSHEA;Washington University School of Medicine, St. Louis, MO Sunday, October 6, 2013 8 – 10 a.m. CLOSING PLENARY SESSION: Global Resistance w Wesley Van Voorhis, MD, PhD, FIDSA; University of Washington, Seattle, WA w Jeanne Marrazzo, MD, FIDSA; University of Washington, Seattle, WA w Brad Spellberg, MD, FIDSA; University of California Los Angeles, Torrance, CA w Sarita Shah, MD, MPH; Centers for Disease Control and Prevention, Atlanta, GA *Titles, dates, and times are subject to change.
    • IDWEEK 2013TM visit: www.idweek.org6 AdultIDTrackAID Tuesday, October 1: Pre-meeting Workshops (additional fees apply) 8 a.m. – 5 p.m. w Best Practices in Antimicrobial Stewardship Programs  w Vincent T. Andriole ID Board Review Course  1 – 5 p.m. w IDSA Maintenance of Certification Workshop: Self-Evaluation of Medical Knowl- edge Modules: General Infectious Diseases 2011 (Updated February 2013), Infections in the Non-HIV Immunocompromised Host   Wednesday, October 2: Pre-meeting Workshops (additional fees apply) 8 a.m. – Noon w Fellows’Day Workshop  w HCV Treatment Options: Opportunities for the ID Practice  w IDSA Maintenance of Certification: Self-Evaluation of Medical Knowledge Modules: HIV 2013 and Hepatitis C  w TB Workshop  Wednesday, October 2: IDWeek Official Program Begins 1:30 – 3:30 p.m. SYMPOSIA w Combination Therapy to Combat Antimicrobial Resistance and Optimize Therapy  w Influenza  w New Insights into the Microbiology and Epidemiology of Multidrug-Resistant Gram-Negative Bacteria  w Payment Reform as the Driver for Healthcare Reform   w Prevention of Healthcare-Associated Infections:The Worldwide Perspective 3:45 – 5:45 p.m. w SPECIAL PLENARY SESSION: Emerging Infections  Thursday, October 3 7 – 8:15 a.m. MINI-SYMPOSIUM w GRADE-ing the Guideline Development Process MEET-THE-PROFESSOR SESSIONS w Early Success and Challenges in Ventilator-Associated Event Reporting to NHSN  w Outpatient Antibiotic Therapy to Address Preventable Hospitalizations  w Power Hour: New Requirements for ABIM MOC in 2014;What ID Physicians Need to Know  w Rapid Diagnostics for Infection Prevention and Antimicrobial Stewardship  w Top 10 Papers in Transplant Infectious Disease  w Travel Medicine for Adults and Children  8:30 – 10 a.m. INTERACTIVE SYMPOSIUM w Clinical Controversies  SYMPOSIA w Human Papillomavirus  w Immunosenescence and Infectious Disease  w Meaningful Antimicrobial Stewardship Outcomes  w Preventing Infection in Healthcare Personnel  w Update on Fungal Diagnostics  8:30 a.m. – 3:30 p.m. SYMPOSIUM w A Reinterpretation of Borders: Lessons Learned from Mycobacterium tuberculosis Pathogenesis  10:30 a.m. – Noon SYMPOSIA w Infections in the Aged:The What, Why, and How  w Infectious Complications of Immunomodulating Biologic Agents  w Polio Eradication  w Relapsing Clostridium difficile Infection (CDI):When Standard Medical Therapy Fails  2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w New IDSA Guideline: Laboratory Diagnosis of Infectious Diseases  SYMPOSIA w Global Viral Threats  w Media, Social Media, and Open Access: Communicating the Science of Infectious Disease  w New Directions for Preventing Surgical Site Infections  w Pertussis  3:45 – 5:45 p.m. NAMED LECTURES w John F. Enders Lecture  w Edward H. Kass Lecture  Friday, October 4 7 – 8:15 a.m. MINI-SYMPOSIUM w Antimicrobial Stewardship Innovations: New Ideas Across the Country   MEET-THE-PROFESSOR SESSIONS w A Users’Guide to Microbiome Analysis  w Changes in SSI Reporting in 2014 and 2015, Implications and Practice Change   w Infectious Complications of Mechanical Circulatory Support Devices  w Management of Severe Viral Respiratory Infections  w Pet-Associated Infections and Zoonoses  w Recognizing Signs and Symptoms of Infection Transmitted Through Transfusion and Transplantation w Wound Care 101  8:30 – 10 a.m. INTERACTIVE SYMPOSIUM w Thorny Issues in Infection Control  SYMPOSIA w Hot Tropical Topics  w Infectious Diseases Diagnostics Update 2013  10:30 a.m. – Noon INTERACTIVE SYMPOSIUM w Challenging Cases in Tropical Medicine  SYMPOSIA w Lessons Learned from Fungal Infections Introduced from the Environment: Epidural Steroid Injections or Natural Disasters  w Management and Prevention of Antibiotic-Resistant Infections in Children  w Transatlantic Milestones in Infection Control:Where are the European Union and the United States Now?  w Vaccines Against Herpes Virus  2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w Susceptibility Breakpoints: Controversies, Challenges, and Changes  SYMPOSIA w Hepatitis C and the Infectious Diseases Community  w Uncommon Presentations of Common Diseases   3:45 – 5:45 p.m. SYMPOSIUM w Chagas Disease: Diagnosis, Transfusion, Management, Transplantation  Saturday, October 5 7 – 8:15 a.m. MINI-SYMPOSIUM w Antimicrobial Pharmacodynamics in Clinical Practice  MEET-THE-PROFESSOR SESSIONS w Diagnosis of Infection in Transplant Recipients  w Infection Prevention and Control During Care of Children and Adults with Cystic Fibrosis  w Infections in Pregnancy and their Prevention  w Leveraging Technology in ID Clinical Care   w Sinus and Ocular Fungal Infections  w The ID Physician Who is New to Infection Prevention  w Virulence Mechanisms as Antimicrobial Targets: Opportunities and Challenges  AdultIDTrack 2013 IDWeek Program Track: Adult ID
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org7 AdultIDTrackAIDAdultIDTrack 2013 IDWeek Program Track: Adult ID (cont’d) 8:30 – 10 a.m. INTERACTIVE SYMPOSIUM w Interactive Cases in Transplant ID  SYMPOSIA w Big Beasts of Infectious Disease  w Fungi and the Microbiome  w New and Near Available Anti-Infective Therapy  w Pneumococcal Disease and Prevention  w Vancomycin-Resistant Enterococcus   10:30 a.m. – Noon SYMPOSIA w Hot Topics in STIs  w Management of the HIV-Transplant Patient  w Update on Emerging Vector-Borne Diseases in the United States  2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w Challenging Cases in ID  SYMPOSIA w Biofilm Biology in Infectious Diseases  w Choosing a Career in Infectious Diseases w Infection Prevention Beyond Hospital Walls  w New Developments in Tuberculosis  3:45 – 5:45 p.m. NAMED LECTURES w Joseph E. Smadel Lecture  w Maxwell Finland Lecture  Sunday, October 6 8 – 10 a.m. w CLOSING PLENARY SESSION: Global Resistance 
    • IDWEEK 2013TM visit: www.idweek.org8 EpidemiologyandInfectionControlTrack Tuesday, October 1: Pre-meeting Workshops (additional fees apply) 8 a.m. – 5 p.m. w Best Practices in Antimicrobial Stewardship Programs  w Vincent T. Andriole ID Board Review Course  Wednesday, October 2: IDWeek Official Program Begins 1:30 – 3:30 p.m. SYMPOSIA w Influenza  w New Insights into the Microbiology and Epidemiology of Multidrug-Resistant Gram-Negative Bacteria  w Payment Reform as the Driver for Healthcare Reform   w Prevention of Healthcare-Associated Infections:The Worldwide Perspective 3:45 – 5:45 p.m. w SPECIAL PLENARY SESSION: Emerging Infections  Thursday, October 3 7 – 8:15 a.m. MINI-SYMPOSIUM w GRADE-ing the Guideline Development Process  MEET-THE-PROFESSOR SESSIONS w Antimicrobial Use and Stewardship in Neonatal ICUs  w Early Success and Challanges in Ventilator-Associated Event Reporting to NHSN  w Rapid Diagnostics for Infection Prevention and Antimicrobial Stewardship  w Red Book Updates  8:30 – 10 a.m. SYMPOSIA w Advances in the Prevention of HAIs in Children  w Human Papillomavirus  w Preventing Infection in Healthcare Personnel  10:30 a.m. – Noon SYMPOSIA w Genomic Tools for Personalized Infectious Diseases Management and Outbreak Investigations  w Infections in the Aged:The What, Why, and How  w Relapsing Clostridium difficile Infection (CDI):When Standard Medical Therapy Fails  w The Environment—A New Frontier  2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w New IDSA Guideline: Laboratory Diagnosis of Infectious Diseases  SYMPOSIA w Global Viral Threats  w Media, Social Media, and Open Access: Communicating the Science of Infectious Disease  w New Directions for Preventing Surgical Site Infections  w Pertussis  3:45 – 5:45 p.m. NAMED LECTURES w John F. Enders Lecture  w Edward H. Kass Lecture  SYMPOSIUM w Translating the Science of MRSA Transmission to Practice  Friday, October 4 7 – 8:15 a.m. MEET-THE-PROFESSOR SESSIONS w Changes in SSI Reporting in 2014 and 2015, Implications and Practice Change   w Infectious Complications of Mechanical Circulatory Support Devices  w Management of Severe Viral Respiratory Infections  w Pet-Associated Infections and Zoonoses  w Preventing Infections Due to Multidrug-Resistant Gram-Negative Rods: Practical Strategies for Acute and Long-Term Care Facilities  w Recognizing Signs and Symptoms of Infection Transmitted Through Transfusion and Transplantation 8:30 – 10 a.m. INTERACTIVE SYMPOSIUM w Thorny Issues in Infection Control  SYMPOSIA w Hot Tropical Topics  w New Insights into the Epidemiology and Prevention of Clostridium difficile Infection  10:30 a.m. – Noon SYMPOSIA w Lessons Learned from Fungal Infections Introduced from the Environment: Epidural Steroid Injections or Natural Disasters  w Management and Prevention of Antibiotic-Resistant Infections in Children  w Transatlantic Milestones in Infection Control:Where are the European Union and the United States Now?  w Vaccines Against Herpes Virus  2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w Susceptibility Breakpoints: Controversies, Challenges, and Changes  SYMPOSIA w Decolonization for MDRO Transmission Prevention:Who, What, Where, Why?  w Hepatitis C and the Infectious Diseases Community  3:45 – 5:45 p.m. NAMED LECTURE w SHEA Lectureship + Top Epidemiology and Infection Control Papers of theYear  3:45 – 5:45 p.m. SYMPOSIUM w Chagas Disease: Diagnosis, Transfusion, Management, Transplantation  Saturday, October 5 7 – 8:15 a.m. MEET-THE-PROFESSOR SESSIONS w Diagnosis of Infection in Transplant Recipients  w Guidance for Healthcare-Associated Infection Surveillance in Nursing Homes  w Infection Prevention and Control During Care of Children and Adults with Cystic Fibrosis  w Leveraging Technology in ID Clinical Care   w The ID Physician Who is New to Infection Prevention  w Virulence Mechanisms as Antimicrobial Targets: Opportunities and Challenges  8:30 – 10 a.m. SYMPOSIA w Pneumococcal Disease and Prevention  w Vancomycin-Resistant Enterococcus   10:30 a.m. – Noon SYMPOSIA w Advanced Design and Analysis of Intervention Studies for HAI Prevention  w Clostridium difficile Infection in Children  w Should Hospital HAI Prevention Policies Translate to Nursing Homes?  w Update on Emerging Vector-Borne Diseases in the United States  2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w Challenging Cases in ID  SYMPOSIA w Biofilm Biology in Infectious Diseases  w Hand Hygiene—Keeping Hands Clean  w Infection Prevention Beyond Hospital Walls  3:45 – 5:45 p.m. NAMED LECTURES w Joseph E. Smadel Lecture  w Maxwell Finland Lecture  Sunday, October 6 8 – 10 a.m. w CLOSING PLENARY SESSION: Global Resistance EPITrackEPI 2013 IDWeek Program Track: Epidemiology and Infection Control
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org9 GlobalIDTrack Tuesday, October 1: Pre-meeting Workshops (additional fees apply) 8 a.m. – 5 p.m. w Vincent T. Andriole ID Board Review Course  1 – 5 p.m. w IDSA Maintenance of Certification Workshop: Self-Evaluation of Medical Knowl- edge Modules: General Infectious Diseases 2011 (Updated February 2013), Infections in the Non-HIV Immunocompromised Host   Wednesday, October 2: Pre-meeting Workshops (additional fees apply) 8 a.m. – Noon w HCV Treatment Options: Opportunities for the ID Practice  w IDSA Maintenance of Certification: Self-Evaluation of Medical Knowledge Modules: HIV 2013 and Hepatitis C  w TB Workshop  Wednesday, October 2: IDWeek Official Program Begins 1:30 – 3:30 p.m. SYMPOSIA w Combination Therapy to Combat Antimicrobial Resistance and Optimize Therapy  w Influenza  w New Insights into the Microbiology and Epidemiology of Multidrug-Resistant Gram-Negative Bacteria  w Prevention of Healthcare-Associated Infections:The Worldwide Perspective w What’s Hot in ID and HIV  3:45 – 5:45 p.m. w SPECIAL PLENARY SESSION: Emerging Infections  Thursday, October 3 7 – 8:15 a.m. MINI-SYMPOSIUM w GRADE-ing the Guideline Development Process  MEET-THE-PROFESSOR SESSIONS w Power Hour: New Requirements for ABIM MOC in 2014;What ID Physicians Need to Know w Travel Medicine for Adults and Children  8:30 – 10 a.m. INTERACTIVE SYMPOSIUM w Clinical Controversies  SYMPOSIA w Human Papillomavirus  w Immunosenescence and Infectious Disease w Meaningful Antimicrobial Stewardship Outcomes  w Preventing Infection in Healthcare Personnel 8:30 a.m. – 3:30 p.m. SYMPOSIUM w A Reinterpretation of Borders: Lessons Learned from Mycobacterium tuberculosis Pathogenesis  10:30 a.m. – Noon SYMPOSIA w Infections in the Aged:The What, Why, and How  w Polio Eradication  2 – 3:30 p.m. SYMPOSIA w Advances in HIV Prevention w Global Viral Threats  w Media, Social Media, and Open Access: Communicating the Science of Infectious Disease w Pertussis  3:45 – 5:45 p.m. NAMED LECTURES w John F. Enders Lecture  w Edward H. Kass Lecture  Friday, October 4 7 – 8:15 a.m. MINI-SYMPOSIUM w Antimicrobial Stewardship Innovations: New Ideas Across the Country MEET-THE-PROFESSOR SESSIONS w A Users’Guide to Microbiome Analysis w Fever and Infection Following Blood Product Transfusion and Organ and Tissue Transplantation w Management of Severe Viral Respiratory Infections  8:30 – 10 a.m. INTERACTIVE SYMPOSIUM w Thorny Issues in Infection Control  SYMPOSIA w Emerging Infections in Children  w Hot Tropical Topics 10:30 a.m. – Noon INTERACTIVE SYMPOSIUM w Challenging Cases in Tropical Medicine SYMPOSIA w Integrating Primary and HIV Care in Special Populations w Lessons Learned from Fungal Infections Introduced from the Environment: Epidural Steroid Injections or Natural Disasters w Transatlantic Milestones in Infection Control:Where are the European Union and the United States Now?  w Vaccines Against Herpes Virus  2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w Susceptibility Breakpoints: Controversies, Challenges, and Changes SYMPOSIUM w Decolonization for MDRO Transmission Prevention:Who, What, Where, Why? 3:45 – 5:45 p.m. SYMPOSIUM w Chagas Disease: Diagnosis, Transfusion, Management, Transplantation  Saturday, October 5 7 – 8:15 a.m. MEET-THE-PROFESSOR SESSIONS w Antimicrobial Pharmacodynamics in Clinical Practice w Infections in Pregnancy and their Prevention  w Sinus and Ocular Fungal Infections  8:30 – 10 a.m. SYMPOSIA w Big Beasts of Infectious Disease w Complex Medical Management in HIV Care w New and Near Available Anti-Infective Therapy w Pneumococcal Disease and Prevention  10:30 a.m. – Noon SYMPOSIUM w Update on Emerging Vector-Borne Diseases in the United States  2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w Challenging Cases in ID  SYMPOSIA w Choosing a Career in Infectious Diseases  w New Developments in Tuberculosis 3:45 – 5:45 p.m. NAMED LECTURES w Joseph E. Smadel Lecture  w Maxwell Finland Lecture  Sunday, October 6 8 – 10 a.m. w CLOSING PLENARY SESSION: Global Resistance GlobalIDTrackGID 2013 IDWeek Program Track: Global ID
    • IDWEEK 2013TM visit: www.idweek.org10 HIV-STD-TBTrackHIVHIV-STD-TBTrack Tuesday, October 1: Pre-meeting Workshops (additional fees apply) 8 a.m. – 5 p.m. w Vincent T. Andriole ID Board Review Course  1 – 5 p.m. w IDSA Maintenance of Certification Workshop: Self-Evaluation of Medical Knowl- edge Modules: General Infectious Diseases 2011 (Updated February 2013), Infections in the Non-HIV Immunocompromised Host   Wednesday, October 2: Pre-meeting Workshops (additional fees apply) 8 a.m. – Noon w HCV Treatment Options: Opportunities for the ID Practice  w IDSA Maintenance of Certification: Self-Evaluation of Medical Knowledge Modules: HIV 2013 and Hepatitis C  Wednesday, October 2: IDWeek Official Program Begins 1:30 – 3:30 p.m. SYMPOSIUM w What’s Hot in ID and HIV 3:45 – 5:45 p.m. w SPECIAL PLENARY SESSION: Emerging Infections  Thursday, October 3 7 – 8:15 a.m. MINI-SYMPOSIUM w GRADE-ing the Guideline Development Process MEET-THE-PROFESSOR SESSIONS w Outpatient Antibiotic Therapy to Address Preventable Hospitalizations w Power Hour: New Requirements for ABIM MOC in 2014;What ID Physicians Need to Know w Update on HIV-Related Guidelines   8:30 – 10 a.m. INTERACTIVE SYMPOSIUM w Clinical Controversies  SYMPOSIUM w Preventing Infection in Healthcare Personnel 10:30 a.m. – Noon INTERACTIVE SYMPOSIUM w HIV Interactive SYMPOSIUM w Infections in the Aged:The What, Why, and How 2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w New IDSA Guideline: Laboratory Diagnosis of Infectious Diseases  SYMPOSIA w Advances in HIV Prevention w Media, Social Media, and Open Access: Communicating the Science of Infectious Disease 3:45 – 5:45 p.m. NAMED LECTURES w John F. Enders Lecture  w Edward H. Kass Lecture  Friday, October 4 7 – 8:15 a.m. MEET-THE-PROFESSOR SESSIONS w A Users’Guide to Microbiome Analysis w HIV Resistance Testing w Recognizing Signs and Symptoms of Infection Transmitted Through Transfusion and Transplantation 8:30 – 10 a.m. SYMPOSIA w HIV State-of-the-Art w Hot Tropical Topics  10:30 a.m. – Noon INTERACTIVE SYMPOSIUM w Challenging Cases in Tropical Medicine SYMPOSIUM w Integrating Primary and HIV Care in Special Populations  2 – 3:30 p.m. SYMPOSIA w Hepatitis C and the Infectious Diseases Community  w Managing Non-ID Co-Morbidities in HIV-Infected Patients  3:45 – 5:45 p.m. SYMPOSIA w Chagas Disease: Diagnosis, Transfusion, Management, Transplantation  w Clinical Challenges in the Management of STD: Interactive Cases and Panel for the ID and HIV Specialist  Saturday, October 5 7 – 8:15 a.m. MEET-THE-PROFESSOR SESSIONS w Leveraging Technology in ID Clinical Care w Sinus and Ocular Fungal Infections  8:30 – 10 a.m. SYMPOSIA w Big Beasts of Infectious Disease  w Complex Medical Management in HIV Care  10:30 a.m. – Noon SYMPOSIA w Hot Topics in STIs w Management of the HIV-Transplant Patient 2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w Challenging Cases in ID  SYMPOSIA w Developments in Diagnostics and Treatment for Tuberculosis w Healthcare Reform and the Future of HIV Care  w New Developments in Tuberculosis 3:45 – 5:45 p.m. NAMED LECTURES w Joseph E. Smadel Lecture  w Maxwell Finland Lecture  Sunday, October 6 8 – 10 a.m. w CLOSING PLENARY SESSION: Global Resistance 2013 IDWeek Program Track: HIV-STD-TB
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org11 InvestigativeIDTrackInvestigativeIDTrackINV Tuesday, October 1: Pre-meeting Workshops (additional fees apply) 8 a.m. – 5 p.m. w Best Practices in Antimicrobial Stewardship Programs  w Vincent T. Andriole ID Board Review Course  Wednesday, October 2: IDWeek Official Program Begins 1:30 – 3:30 p.m. SYMPOSIA w Combination Therapy to Combat Antimicrobial Resistance and Optimize Therapy  w Influenza  w New Insights into the Microbiology and Epidemiology of Multidrug-Resistant Gram-Negative Bacteria  w Prevention of Healthcare-Associated Infections:The Worldwide Perspective 3:45 – 5:45 p.m. w SPECIAL PLENARY SESSION: Emerging Infections  Thursday, October 3 7 – 8:15 a.m. MINI-SYMPOSIUM w GRADE-ing the Guideline Development Process  MEET-THE-PROFESSOR SESSIONS w Early Success and Challenges in Ventilator-Associated Event Reporting to NHSN w Power Hour: New Requirements for ABIM MOC in 2014;What ID Physicians Need to Know w Top 10 Papers in Transplant Infectious Disease  8:30 – 10 a.m. SYMPOSIA w Immunosenescence and Infectious Disease  w Meaningful Antimicrobial Stewardship Outcomes  w Preventing Infection in Healthcare Personnel  8:30 a.m. – 3:30 p.m. SYMPOSIUM w A Reinterpretation of Borders: Lessons Learned from Mycobacterium tuberculosis Pathogenesis  10:30 a.m. – Noon SYMPOSIA w Infections in the Aged:The What, Why, and How  w Relapsing Clostridium difficile Infection (CDI):When Standard Medical Therapy Fails  2 – 3:30 p.m. SYMPOSIA w Media, Social Media, and Open Access: Communicating the Science of Infectious Disease  w Pertussis  3:45 – 5:45 p.m. NAMED LECTURES w John F. Enders Lecture  w Edward H. Kass Lecture  Friday, October 4 7 – 8:15 a.m. MINI-SYMPOSIUM w Antimicrobial Stewardship Innovations: New Ideas Across the Country MEET-THE-PROFESSOR SESSIONS w A Users’Guide to Microbiome Analysis  w Changes in SSI Reporting in 2014 and 2015, Implications and Practice Change w Management of Severe Viral Respiratory Infections  8:30 – 10 a.m. INTERACTIVE SYMPOSIUM w Thorny Issues in Infection Control  SYMPOSIUM w Hot Tropical Topics  10:30 a.m. – Noon SYMPOSIA w Lessons Learned from Fungal Infections Introduced from the Environment: Epidural Steroid Injections or Natural Disasters  w Transatlantic Milestones in Infection Control:Where are the European Union and the United States Now?  2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w Susceptibility Breakpoints: Controversies, Challenges, and Changes SYMPOSIUM w Hepatitis C and the Infectious Diseases Community  3:45 – 5:45 p.m. SYMPOSIUM w Chagas Disease: Diagnosis, Transfusion, Management, Transplantation Saturday, October 5 7 – 8:15 a.m. MEET-THE-PROFESSOR SESSIONS w Antimicrobial Pharmacodynamics in Clinical Practice  w Sinus and Ocular Fungal Infections  w Virulence Mechanisms as Antimicrobial Targets: Opportunities and Challenges  8:30 – 10 a.m. SYMPOSIA w Fungi and the Microbiome  w New and Near Available Anti-Infective Therapy w Pneumococcal Disease and Prevention  w Vancomycin-Resistant Enterococcus   10:30 a.m. – Noon SYMPOSIUM w Advanced Design and Analysis of Intervention Studies for HAI Prevention  2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w Challenging Cases in ID  SYMPOSIUM w Biofilm Biology in Infectious Diseases  3:45 – 5:45 p.m. NAMED LECTURES w Joseph E. Smadel Lecture  w Maxwell Finland Lecture  Sunday, October 6 8 – 10 a.m. w CLOSING PLENARY SESSION: Global Resistance 2013 IDWeek Program Track: Investigator ID
    • IDWEEK 2013TM visit: www.idweek.org12 PediatricIDTrackPIDPediatricIDTrack Tuesday, October 1: Pre-meeting Workshops (additional fees apply) 8 a.m. – 5 p.m. w Best Practices in Antimicrobial Stewardship Programs  w Vincent T. Andriole ID Board Review Course  Wednesday, October 2: Pre-meeting Workshops (additional fees apply) 8 a.m. – Noon w Pediatric Fellows’Day Workshop  w TB Workshop  Wednesday, October 2: IDWeek Official Program Begins 1:30 – 3:30 p.m. INTERACTIVE SYMPOSIUM w Challenging Cases in Pediatric Infectious Diseases SYMPOSIA w Influenza  w New Insights into the Microbiology and Epidemiology of Multidrug-Resistant Gram-Negative Bacteria  w Prevention of Healthcare-Associated Infections:The Worldwide Perspective 3:45 – 5:45 p.m. w SPECIAL PLENARY SESSION: Emerging Infections  Thursday, October 3 7 – 8:15 a.m. MINI-SYMPOSIUM w GRADE-ing the Guideline Development Process MEET-THE-PROFESSOR SESSIONS w Antimicrobial Use and Stewardship in Neonatal ICUs  w Outpatient Antibiotic Therapy to Address Preventable Hospitalizations  w Red Book Updates  w Travel Medicine for Adults and Children  8:30 – 10 a.m. SYMPOSIA w Advances in the Prevention of HAIs in Children  w Human Papillomavirus w Preventing Infection in Healthcare Personnel  8:30 a.m. – 3:30 p.m. SYMPOSIUM w A Reinterpretation of Borders: Lessons Learned from Mycobacterium tuberculosis Pathogenesis  10:30 a.m. – Noon SYMPOSIA w Infectious Complications of Immunomodulating Biologic Agents  w Polio Eradication  w Relapsing Clostridium difficile Infection (CDI):When Standard Medical Therapy Fails  2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w New IDSA Guideline: Laboratory Diagnosis of Infectious Diseases  SYMPOSIA w Global Viral Threats  w Media, Social Media, and Open Access: Communicating the Science of Infectious Disease  w Pertussis  3:45 – 5:45 p.m. NAMED LECTURES w John F. Enders Lecture  w Edward H. Kass Lecture  Friday, October 4 7 – 8:15 a.m. MEET-THE-PROFESSOR SESSIONS w Changes in SSI Reporting in 2014 and 2015, Implications and Practice Change w Infectious Complications of Mechanical Circulatory Support Devices w Management of Severe Viral Respiratory Infections  w Pet-Associated Infections and Zoonoses w Recognizing Signs and Symptoms of Infection Transmitted Through Transfusion and Transplantation 8:30 – 10 a.m. INTERACTIVE SYMPOSIUM w Thorny Issues in Infection Control SYMPOSIA w Emerging Infections in Children  w Hot Tropical Topics  10:30 a.m. – Noon INTERACTIVE SYMPOSIUM w Challenging Cases in Tropical Medicine  SYMPOSIA w Lessons Learned from Fungal Infections Introduced from the Environment: Epidural Steroid Injections or Natural Disasters w Management and Prevention of Antibiotic-Resistant Infections in Children  w Transatlantic Milestones in Infection Control:Where are the European Union and the United States Now?  w Vaccines Against Herpes Virus 2 – 3:30 p.m. SYMPOSIUM w Pediatric Transplant ID  3:45 – 5:45 p.m. SYMPOSIA w Chagas Disease: Diagnosis, Transfusion, Management, Transplantation  w Hot Topics in Pediatric Infectious Diseases Saturday, October 5 7 – 8:15 a.m. MEET-THE-PROFESSOR SESSIONS w Antimicrobial Pharmacodynamics in Clinical Practice  w Diagnosis of Infection in Transplant Recipients w Infection Prevention and Control During Care of Children and Adults with Cystic Fibrosis w Infections in Pregnancy and their Prevention w Kawasaki Disease:Where are We Now?  w Sinus and Ocular Fungal Infections w The ID Physician Who is New to Infection Prevention  8:30 – 10 a.m. INTERACTIVE SYMPOSIUM w Interactive Cases in Transplant ID  SYMPOSIA w Big Beasts of Infectious Disease  w Fungi and the Microbiome  w Pneumococcal Disease and Prevention  10:30 a.m. – Noon SYMPOSIA w Clostridium difficile Infection in Children w Update on Emerging Vector-Borne Diseases in the United States  2 – 3:30 p.m. INTERACTIVE SYMPOSIUM w Challenging Cases in ID  SYMPOSIA w Choosing a Career in Infectious Diseases  w Infection Prevention Beyond Hospital Walls w New Developments in Tuberculosis 3:45 – 5:45 p.m. NAMED LECTURES w Joseph E. Smadel Lecture  w Maxwell Finland Lecture  Sunday, October 6 8 – 10 a.m. w CLOSING PLENARY SESSION: Global Resistance 2013 IDWeek Program Track: Pediatric ID
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org13 PRE-MEETING WORKSHOPS (Additional Fees Apply) Tuesday, October 1, 2013 Adult ID / Epidemiology and Infection Control / Investigative ID / Pediatric ID Best Practices in Antimicrobial Stewardship Programs Pre-meeting Workshop 8 a.m. – 5 p.m. Co-organized with the Society of Infectious Diseases Pharmacists Audience: Healthcare stewardship providers who desire to create, implement, or improve antimicrobial stewardship programs for their healthcare institutions. Individuals representing community- based hospitals are particularly targeted for this activity; however, individuals representing all sizes of institutions will find the content relevant to their needs. Pharmacists, microbiologists, infectious diseases physicians, infectious diseases pediatricians, infection preventionists, hospital epidemiologists, epidemiologists, academicians Objectives: At the conclusion of this workshop, participants will be able to: • evaluate components of effective antimicrobial stewardship programs • outline strategies for identifying and implementing process and outcomes measures • describe antimicrobial stewardship interventions for unique populations, including outpatient settings, neonates, and pediatric populations • critically assess available data, including pharmacy and microbiology data, and the informatics strategies needed to support antimicrobial stewardship in their institutions Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID Vincent T. Andriole ID Board Review Course Pre-meeting Workshop 8 a.m. – 5 p.m. Audience: infectious diseases physicians, members-in-training Objectives: At the conclusion of this session, participants will be able to: • discuss and apply updated information on diagnosis and treatment of sexually transmitted diseases • summarize and apply latest treatments for central nervous system (CNS) infections: meningitis and encephalitis • discuss and apply updated information on diagnosis and treatment of bone and joint infections • discuss the most current diseases of travelers and apply updates to patient care • evaluate components of effective antimicrobial stewardship infection control programs, implement interventions in healthcare settings, and implement interventions for unique populations, outpatient settings, neonates, and pediatric populations • critically assess available data, including pharmacy and microbiology data, and the informatics strategies needed to support antimicrobial stewardship in healthcare settings • determine best treatments for transplant-associated infections • discuss current information on diagnosing and treating fungal infections • assess and apply current trends in HIV care • assess and apply current information regarding diagnosis and treatment of endocarditis • assess causes and devise effective management of diarrhea • discuss the causes and treatment modalities of zoonotic infections Adult ID / Global ID / HIV-STD-TB IDSA Maintenance of Certification Workshop: Self- Evaluation of Medical Knowledge Modules: General Infectious Diseases 2011 (Updated February 2013), Infections in the Non-HIV Immunocompromised Host Pre-meeting Workshop 1 – 5 p.m. Co-organized with the Wake Forest University School of Medicine Audience: academicians, clinicians, epidemiologists, fellows, HIV clinicians, HIV specialists, hospital epidemiologists, infectious diseases pediatricians, infectious diseases physicians, members-in- training, microbiologists Objectives: This interactive workshop will provide a review of two, 25-question IDSA Maintenance of Certification (MOC) modules and will allow attendees to earn 20 points toward American Board of Internal Medicine (ABIM) recertification. The discussion will consist of a review of each question and the right and wrong answers, accompanied by teaching slides for the 2011 General ID and the Non-HIV Immunocompromised Host Modules. Following the workshop, attendees can upload the suggested correct responses to the online IDSA MOC platform and earn ABIM credit. At the conclusion of this session, attendees will be able to: • discuss evidence supporting answer choices in 25 ID and 25 infections in the non-HIV immunocompromised host case scenarios • apply updated information to the management of common infectious diseases in various hosts • summarize new treatment and diagnostic strategies in common infectious diseases, including infections in the non-HIV immunocompromised host *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org
    • IDWEEK 2013TM visit: www.idweek.org14 Wednesday, October 2, 2013 Adult ID Fellows’ Day Workshop (Adult and General ID) Pre-meeting Workshop 8 a.m. – Noon Co-organized with the IDSA ID Training Program Directors’ Committee Audience: members-in-training, medical students and residents Objectives: At the conclusion of this activity, participants will be able to: • identify an infectious disease outbreak and implement an outbreak mitigation plan • manage many of the non-medical aspects of treating a patient with hepatitis C • utilize best strategies when interacting with the media • establish an acute infections outpatient clinic Adult ID HCV Treatment Options: Opportunities for the ID Practice Pre-meeting Workshop 8 a.m. – Noon Co-organized with the IDSA Clinical Affairs Committee and Hepatitis Task Force Audience: clinicians, fellows, HIV clinicians, infectious diseases physicians, members-in-training Objectives: Case presentations will be used throughout this work- shop.  At the conclusion of this session, participants will be able to: • discuss new screening guidelines and non-invasive modalities for assessment of liver damage • identify the latest drugs approved for both hepatitis C virus (HCV) mono-infection and HCV/HIV co-infection along with the treatment and management guidelines for both naïve, and experienced patients • implement strategies to optimize office management for HCV patients • identify medical problems common to HCV patients • recite the basics of care of the compensated cirrhotic patients Adult ID / Global ID / HIV-STD-TB IDSA Maintenance of Certification: Self-Evaluation of Medical Knowledge Modules: HIV 2013 and Hepatitis C Pre-meeting Workshop 8 a.m. – Noon Co-organized with the Wake Forest University School of Medicine Audience: academicians, clinicians, epidemiologists, fellows, HIV clinicians, HIV specialists, hospital administrators, hospital epidemiologists, infectious diseases pediatricians, infectious diseases physicians, members-in-training, microbiologists, pharmacists, public health practitioners Objectives: This interactive workshop will provide a review of two, 25-question IDSA Maintenance of Certification (MOC) modules and will allow attendees to earn 20 points toward American Board of Internal Medicine (ABIM) recertification. Moderators will review each question from the new 2013 MOC modules, including a discussion of the right and wrong answers. Following the workshop, attendees can upload the suggested correct responses to the online IDSA MOC platform and earn ABIM credit recertification. At the conclusion of this session, attendees will be able to: • discuss evidence supporting answer choices in 25 case scenarios on HIV medicine and 25 case scenarios on hepatitis C evaluation and management • apply updated information to clinical scenarios in HIV and hepatitis C medicine • summarize new treatment and diagnostic strategies in these hosts Pediatric ID Pediatric Fellows’ Day Workshop Pre-meeting Workshop 8 a.m. – Noon Co-organized with the PIDS Training Programs Committee Audience: members-in-training, medical students and residents Objectives: At the conclusion of this workshop, attendees will be able to: • discuss challenging infectious disease cases and approaches to patient management • highlight career opportunities and pathways to achieve professional goals • review issues related to finding a job after fellowship Adult ID / Global ID / Pediatric ID TB Workshop Pre-meeting Workshop 8 a.m. – Noon Co-organized with the Center for Global Health Policy Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, members- in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • review the pipeline of new drugs and recent or ongoing studies of new strategies for treating active tuberculosis (TB) • provide updated recommendations for preventing, diagnosing, and treating mycobacterial infections in the setting of tumor necrosis factor (TNF)-inhibitors or other immuno-modulating agents • review the latest data about what programmatic interventions are effective in high burden settings • provide alternative viewpoints for whether targeted versus generalized adoption of interferon-gamma release assay (IGRA) for diagnosis of TB infection is most cost-effective • review successful strategies for treating multidrug-resistant (MDR) TB in the United States PRE-MEETING WORKSHOPS continued
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org15 *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org SCIENTIFIC PROGRAM Wednesday, October 2, 2013 Pediatric ID Challenging Cases in Pediatric Infectious Diseases Interactive Session 1:30 – 3:30 p.m. Co-organized with the American Academy of Pediatrics Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in-training, microbiologists, nurses, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • analyze and formulate differential diagnoses and management plans for challenging cases • cite medical evidence and current expert opinion in management and prevention of infections • assess and compare knowledge anonymously with peers • identify unusual infectious diseases in children Adult ID / Global ID / Investigative ID Combination Therapy to Combat Antimicrobial Resistance and Optimize Therapy Symposium 1:30 – 3:30 p.m. Audience: academicians, clinicians, fellows, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • identify various options for combination therapy to treat patients with Gram-negative bacterial pneumonia and infections arising from Gram-positive pathogens, Mycobacterium tuberculosis, and Aspergillus • explain the combinations of agents for each of the above- described infections that have been associated with optimized outcomes Adult ID / Epidemiology and Infection Control / Global ID / Investigative ID / Pediatric ID Influenza Symposium 1:30 – 3:30 p.m. Co-organized with the Center for Global Health Policy Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • describe the threat of evolving and novel influenza viruses • compare the rapidly increasing types of influenza vaccine • define the pathways and barriers in the search for improved influenza vaccines Adult ID / Epidemiology and Infection Control / Global ID / Investigative ID / Pediatric ID New Insights into the Microbiology and Epidemiology of Multidrug-Resistant Gram-Negative Bacteria Symposium 1:30 – 3:30 p.m. Co-organized with the European Society of Clinical Microbiology and Infectious Diseases Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • describe the epidemiology of emerging carbapenemases, including New Delhi metallo-β-lactamase (NDM) and OXAs, inside and outside of healthcare settings worldwide • recognize the effect of natural environmental factors on the spread of antibiotic-resistance in Gram-negative bacteria • list advantages and disadvantages of different laboratory methods for the detection of carbapanemase-producing bacteria in clinical and surveillance specimens • discuss the clinical consequences and infection control implications of the increasing incidence of community infections due to extended spectrum β-lactamase (ESBL)-producing Enterobacteriaceae
    • IDWEEK 2013TM visit: www.idweek.org16 Adult ID / Epidemiology and Infection Control Payment Reform as the Driver for Healthcare Reform Symposium 1:30 – 3:30 p.m. Co-organized with the IDSA Clinical Affairs Committee Audience: clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in- training, nurses, pharmacists Objectives: At the conclusion of this session, participants will be able to: • describe how quality metrics related to healthcare-associated infections (HAIs) are tied to the value-based payment modifier for healthcare facilities (as delineated in the National Action Plan for HAIs) • explain how cognitive specialists function in the “Primary Care Medical Home-Neighborhood” • recognize the advantages and pitfalls of measuring infection- related outcomes on a system level in an accountable care organization (ACO) • plan how to use the Value of ID toolkit to promote your value to hospital and health plan administrators Adult ID / Epidemiology and Infection Control / Global ID / Investigative ID / Pediatric ID Prevention of Healthcare-Associated Infections: The Worldwide Perspective Symposium 1:30 – 3:30 p.m. Audience: academicians, clinicians, epidemiologists, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians Objectives: At the conclusion of this session, participants will be able to: • describe the behavior change interventions with greater precision, predictability, and pace towards reduction in neonatal mortality • list the challenges of preventing surgical site infections in a resource-limited setting • discuss prevention and control in the healthcare settings for tuberculosis HIV-STD-TB What’s Hot in ID and HIV Symposium 1:30 – 3:30 p.m. Co-organized with the Center for Global Health Policy Audience: clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, public health practitioners, researchers Objectives: At the conclusion of this session, participants will be able to: • outline clinically significant research findings in ID and HIV over the past year • describe basic science findings likely to impact clinical practice within the next year • describe how research advances in the past year will impact their practice Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID Special Plenary Session: Emerging Infections Plenary Session 3:45 – 5:45 p.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • understand the challenges faced by physicians managing patients with severe novel clinical syndromes • appreciate the lessons that can be learned from formal and systematic clinical investigation of emerging infectious disease • discuss how clinical experience in dispersed localities can be globally applied • describe the critical role of communication in instilling trust during outbreaks caused by new or novel agents • identify strategies for addressing communication challenges • understand how to avoid pitfalls that can present themselves Speakers: Investigating Emerging Infectious Diseases at the Bedside Jeremy Farrar, MD, PhD; Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam Emerging Infectious Disease Outbreaks: Using Communication to Shape a Health Crisis Richard Besser, MD; ABC News, New York, NY Wednesday, October 2 continued
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org17 *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org Thursday, October 3, 2013 Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID GRADE-ing the Guideline Development Process Mini-Symposium 7 – 8:15 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, hospital epidemiologists, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in- training, nurses, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • describe how the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) process should be applied in making evidence-based recommendations • review national and international use of GRADE, and professional society requirements for GRADE • review the processes and challenges in integrating GRADE into the culture of the Advisory Committee on Immunization Practices (ACIP), and highlight how ACIP recommendations have benefited from the GRADE process • summarize how IDSA guidelines benefit from the GRADE process Epidemiology and Infection Control / Pediatric ID Antimicrobial Use and Stewardship in Neonatal ICUs Meet-the-Professor Session 7 – 8:15 a.m. Audience: clinicians, epidemiologists, fellows, healthcare workers, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, medical students and residents, members-in-training, nurses, pharmacists, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • describe patterns of antimicrobial utilization in neonatal ICUs, including patterns of empiric and definitive antimicrobial therapy for common conditions • identify important adverse effects of antimicrobial treatment in this population • apply antimicrobial stewardship strategies to improve antimicrobial use in neonatal ICUs in their institutions Adult ID / Epidemiology and Infection Control / Investigative ID Early Success and Challenges in Ventilator- Associated Event Reporting to NHSN Meet-the-Professor Session 7 – 8:15 a.m. Audience: epidemiologists, hospital epidemiologists, infection preventionists, infectious diseases physicians, microbiologists, public health practitioners, researchers, scientists Objectives: Challenges with accuracy, sustainability, and clinical relevance of ventilator-associated pneumonia (VAP) surveillance have been well described. With extensive input and support from the critical care professional community, CDC’s National Healthcare Safety Network (NHSN) retired VAP surveillance in adults as of 2012, and began surveillance of ventilator-associated events (VAE) in 2013. Assessments of the feasibility of performing VAE surveillance, clinical relevance, and correlation of changes in measures of this event alongside VAP prevention initiatives are eagerly anticipated. This session will present a summary of the early experience with this surveillance in NHSN, problems and solutions in development, and data demonstrating the clinical relevance of VAE in the context of active VAP prevention efforts. At the conclusion of this session, participants will be able to: • describe the key aspects of initiating surveillance for VAE, maximizing efficiency based on the experience of early adopters in NHSN • cite and implement any necessary modifications to VAE surveillance coming for 2014 • describe key components of effective VAP prevention bundles • describe the current evidence that implementation of VAP prevention bundle (Wake up and Breathe) is associated with decreased VAE, and improved patient outcomes Adult ID / HIV-STD-TB / Pediatric ID Outpatient Antibiotic Therapy to Address Preventable Hospitalizations Meet-the-Professor Session 7 – 8:15 a.m. Co-organized with the IDSA Clinical Affairs Committee Audience: clinicians, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital administrators, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in-training Objectives: At the conclusion of this session, participants will be able to: • describe strategies for cost-effective, high-quality care through the avoidance of unnecessary hospital admissions and re-admissions due to acute infections
    • IDWEEK 2013TM visit: www.idweek.org18 Thursday, October 3 continued • identify patients who can be appropriately managed in the outpatient setting • list best practices for improved systems of care and management of specific diseases Adult ID / Global ID / HIV-STD-TB / Investigative ID Power Hour: New Requirements for ABIM MOC in 2014; What ID Physicians Need to Know Meet-the-Professor Session 7 – 8:15 a.m. Co-organized with the IDSA Education Committee Audience: academicians, clinicians, HIV clinicians, infectious diseases physicians, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • discuss in an interactive format the Maintenance of Certification (MOC) process for certification in infectious diseases by the American Board of Internal Medicine (ABIM) • identify changes to the ABIM MOC process taking effect in 2014, including how certification is maintained and represented to the public • identify MOC products available for ID clinicians Adult ID / Epidemiology and Infection Control Rapid Diagnostics for Infection Prevention and Antimicrobial Stewardship Meet-the-Professor Session 7 – 8:15 a.m. Co-organized with the Society of Infectious Diseases Pharmacists Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infection preventionists, infectious diseases physicians, investigators, medical students and residents, members-in-training, microbiologists, public health practitioners, researchers Objectives: At the conclusion of this session, participants will be able to: • describe the rapid diagnostic platforms to detect methicillin- resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and Clostridium difficile colonization and infections • discuss the clinical value of rapidly identifying MRSA, VRE, and C. difficile in terms of patient outcomes, antimicrobial stewardship, and overall hospital costs • describe a model to integrate prompt diagnosis of bloodstream infection with antimicrobial stewardship Epidemiology and Infection Control / Pediatric ID Red Book Updates Meet-the-Professor Session 7 – 8:15 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • discuss the structure of and changes to the 2013 American Academy of Pediatrics Report on the Committee of Infectious Diseases (Red Book) • recognize changes since the 2013 Red Book • utilize interactive features of the 2013 Red Book and Red Book online Adult ID / Investigative ID Top 10 Papers in Transplant Infectious Disease Meet-the-Professor Session 7 – 8:15 a.m. Co-organized with the International Immunocompromised Host Society Audience: academicians, clinicians, fellows, infectious diseases physicians, investigators, pharmacists, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • describe new developments in the diagnosis, prevention, and treatment of infections in the solid-organ transplant recipient • describe new developments in the hematopoietic cell transplant recipient Adult ID / Global ID / Pediatric ID Travel Medicine for Adults and Children Meet-the-Professor Session 7 – 8:15 a.m. Audience: clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in-training, vaccinologists Objectives: TBD
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org19 *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org Thursday, October 3 continued HIV-STD-TB Update on HIV-Related Guidelines Meet-the-Professor Session 7 – 8:15 a.m. Audience: clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases physicians, medical students and residents, members-in-training, researchers Objectives: At the conclusion of this session, participants will be able to: • describe updates to HIV care and treatment guidelines • apply the latest standard for HIV care to their practice Adult ID Clinical Controversies Interactive Session 8:30 – 10 a.m. Co-organized with the IDSA Clinical Affairs Committee and the Center for Global Health Policy Audience: clinicians, fellows, hospital administrators, hospital epi- demiologists, infection preventionists, infectious diseases physicians, medical students and residents, members-in-training Objectives: This session is intended for all clinicians and trainees who provide preventive or direct patient care in infectious diseases.  It is assumed that the participant has a basic understanding of the unresolved issues reflected in the topics for this session.  At the conclusion of this session, participants will be able to weigh points debated and gain an understanding of “both sides” of the controversy. Epidemiology and Infection Control / Pediatric ID Advances in the Prevention of HAIs in Children Symposium 8:30 – 10 a.m. Audience: clinicians, epidemiologists, fellows, healthcare workers, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, medical students and residents, members-in-training, nurses, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • describe the effect of interventions to prevent surgical site infections, catheter-associated bloodstream infections, and dialysis-related infections among children in hospitals participating in nationwide, multi-center improvement initiatives • identify factors that facilitate reliable implementation of effective interventions • apply lessons learned from these initiatives in their own institutions Adult ID / Epidemiology and Infection Control / Global ID / Pediatric ID Human Papillomavirus Symposium 8:30 – 10 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • describe the burden of human papillomavirus (HPV)-associated disease • describe the current immunization program and impact in the United States • define vaccine hesitancy issues that need to be addressed Adult ID / Global ID / Investigative ID Immunosenescence and Infectious Disease Symposium 8:30 – 10 a.m. Audience: academicians, clinicians, epidemiologists, fellows, infection preventionists, infectious diseases physicians, pharmacists, public health practitioners, scientists, vaccinologists Objectives: tbd Adult ID / Global ID / Investigative ID Meaningful Antimicrobial Stewardship Outcomes Symposium 8:30 – 10 a.m. Co-organized with the Society of Infectious Diseases Pharmacists and developed in collaboration with the National Institute of Allergy and Infectious Diseases Audience: academicians, clinicians, fellows, hospital administrators, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • explain accountable care organization measures used for antimicrobial stewardship programs • identify safety-related antimicrobial stewardship measures • describe measures of microbial ecology for antimicrobial stewardship programs
    • IDWEEK 2013TM visit: www.idweek.org20 Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID Preventing Infection in Healthcare Personnel Symposium 8:30 – 10 a.m. Co-organized by the European Society of Clinical Microbiology and Infectious Diseases Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • describe the approach to evaluating and determining exposure in situations of suspected drug diversion • list the new recommendations for vaccination in healthcare personnel • discuss and implement strategies used to maximize vaccination among healthcare personnel • review the perceived and real risks for immunocompromised healthcare personnel Adult ID Update on Fungal Diagnostics Symposium 8:30 – 10 a.m. Audience: clinicians, fellows, infectious diseases physicians, microbiologists, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • review the performance of diagnostic tests for invasive candidiasis and mould infections in different clinical settings • explore how data from diagnostic tests can reshape concepts of disease, colonization, and pathogenesis for invasive candidiasis and mould infections • consider the questions that should be asked in future diagnostic studies • review the current performance of molecular tests for the detection and quantification of Aspergillus DNA • discuss approaches to standardizing molecular tests • review the potential of newer diagnostic tests for aspergillosis and invasive candidiasis to influence the current pre-emptive therapeutic approaches to these infections in the nosocomial setting • explore the impact of new assays for cryptococcal disease on early intervention programs among at-risk populations • review future developments in the early diagnosis of histoplasmosis and coccidioidomycosis Adult ID / Global ID / Investigative ID / Pediatric ID A Reinterpretation of Borders: Lessons Learned from Mycobacterium tuberculosis Pathogenesis Symposium 8:30 a.m. – 3:30 p.m. Co-organized with the Center for Global Health Policy Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • discuss mechanisms by which Mycobacterium tuberculosis causes chronic infection • review ongoing TB-specific vaccine efforts • describe the epidemiology of Mycobacterium tuberculosis infection HIV-STD-TB HIV Interactive Interactive Session 10:30 a.m. – Noon Audience: clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases physicians, medical students and residents, members-in-training, public health practitioners, researchers Objectives: At the conclusion of this session, participants will be able to: • identify complicating variables in HIV cases • apply HIV treatment strategies to complicated variables • identify alternate treatment strategies for HIV Epidemiology and Infection Control Genomic Tools for Personalized Infectious Diseases Management and Outbreak Investigations Symposium 10:30 a.m. – Noon Co-organized with British Columbia Centre for Disease Control Audience: academicians, clinicians, epidemiologists, fellows, hospital epidemiologists, infection preventionists, medical students and residents, members-in-training, microbiologists, public health practitioners, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • describe the most common whole genome sequencing platforms and their integration with epidemiology Thursday, October 3 continued
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org21 *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org Thursday, October 3 continued • discuss the use of whole genome sequencing for specific outbreak investigations and the role of the infectious disease (ID) physician in result interpretation • identify genomic tools that can evaluate an individual’s susceptibility to ID and individualized genomic responses to infections Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID Infections in the Aged: The What, Why, and How Symposium 10:30 a.m. – Noon Audience: academicians, clinicians, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital epidemiologists, infectious diseases physicians, investigators, medical students and residents, members-in-training, microbiologists, nurses, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • apply knowledge of infectious diseases to contrast their burden in the elderly • evaluate the role of inflammation in response to infectious diseases in the elderly with particular attention to an aging HIV- infected population • explain the role of the microbiome in health and disease in older persons Adult ID / Pediatric ID Infectious Complications of Immunomodulating Biologic Agents Symposium 10:30 a.m. – Noon Co-organized with the Transplant Infectious Disease and Compromised Host Interest Group Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in-training, microbiologists, nurses, pharmacists Objectives: At the conclusion of this session, participants will be able to: • review the mechanism of action of current immunomodulating biologic agents • discuss the role of biologics in the management of oncologic and hematologic malignancies including stem cell transplantation, solid organ transplantation, and autoimmune diseases • describe the important infectious complications associated with these novel drugs Adult ID / Global ID / Pediatric ID Polio Eradication Symposium 10:30 a.m. – Noon Co-organized with the Center for Global Health Policy Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, nurses, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • explain the challenges and obstacles involved in polio eradication • review the vaccine needs currently and in the post-eradication era • describe the potential role of antiviral drugs in eradication of polio Adult ID / Epidemiology and Infection Control / Investigative ID / Pediatric ID Relapsing Clostridium difficile Infection (CDI): When Standard Medical Therapy Fails Symposium 10:30 a.m. – Noon Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • describe the fecal microbiome in health and how the altered microbiome sets the stage for relapsing Clostridium difficile infection (CDI) • outline the various approaches to administer fecal microbiome therapy (FMT) and how to get paid for providing FMT • appreciate alternative treatment strategies using stool substitution therapy to resolve relapsing CDI Epidemiology and Infection Control The Environment—A New Frontier Symposium 10:30 a.m. – Noon Audience: epidemiologists, hospital epidemiologists, infection preventionists, researchers, scientists
    • IDWEEK 2013TM visit: www.idweek.org22 Objectives: At the conclusion of this session, participants will be able to: • apply methods to standardize cleaning practices in healthcare • describe current controversies about infection prevention practices for procedures that do not occur in the operating room Adult ID / Epidemiology and Infection Control / HIV-STD-TB / Pediatric ID New IDSA Guideline: Laboratory Diagnosis of Infectious Diseases Interactive Session 2 – 3:30 p.m. Co-organized with the IDSA Practice Guidelines Committee Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, lab personnel, microbiologists, nurses, pharmacists, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • apply the new IDSA guideline to specific cases as presented by the moderators • select appropriate diagnostic tests for diagnosis of infections caused by bacteria, parasites, viruses, and fungi • utilize the new IDSA guideline in their clinical practice Global ID / HIV-STD-TB Advances in HIV Prevention Symposium 2 – 3:30 p.m. Co-organized with the Center for Global Health Policy Audience: clinicians, epidemiologists, fellows, HIV clinicians, HIV specialists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, public health practitioners, researchers Objectives: At the conclusion of this session, participants will be able to: • apply new HIV testing protocols and the use of rapid diagnostic HIV tests to their practice • describe the latest advances in biomedical prevention tools and research • identify and implement novel approaches to HIV prevention targeting most-at-risk populations to prevent HIV transmission Adult ID / Epidemiology and Infection Control / Global ID / Pediatric ID Global Viral Threats Symposium 2 – 3:30 p.m. Co-organized with the Center for Global Health Policy Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • describe epidemiologic features of dengue in travelers • identify lessons learned from polio eradication efforts in India applicable to current endemic countries • explain the role of ProMed in recognition and response to the novel coronavirus in the Middle East Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID Media, Social Media, and Open Access: Communicating the Science of Infectious Disease Symposium 2 – 3:30 p.m. Co-organized with the Center for Global Health Policy Audience: infectious diseases physicians, microbiologists, public health practitioners, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • recall benefits and steps of communicating your science with the general public through multiple means • identify techniques to improve communication with the media • list advantages of publication in open-access journals and how to encourage such publication at academic institutions Adult ID / Epidemiology and Infection Control New Directions for Preventing Surgical Site Infections Symposium 2 – 3:30 p.m. Audience: clinicians, epidemiologists, fellows, hospital epidemiologists, infection preventionists, public health practitioners Thursday, October 3 continued
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org23 *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org Thursday, October 3 continued Speaker: What it Takes to Prevent Influenza Disease Nancy Cox, PhD; Centers for Disease Control and Prevention, Atlanta, GA Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID Edward H. Kass Lecture Named Lecture 5 – 5:45 p.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • identify the major neglected tropical diseases (NTD) and how they cause poverty • discuss global approaches to NTD control including mass drug administration and preventive chemotherapy • review where the NTDs occur, especially among the poor living in middle income and wealthy countries • cite the opportunities for science and vaccine diplomacy Speaker: The NTDs and Blue Marble Health Peter Hotez, MD, PhD; Baylor College of Medicine and Texas Children’s Hospital, Houston, TX Epidemiology and Infection Control Translating the Science of MRSA Transmission to Practice Symposium 3:45 – 5:45 p.m. Audience: clinicians, epidemiologists, fellows, hospital administrators, hospital epidemiologists, infection preventionists, microbiologists, nurses, researchers Objectives: At the conclusion of this session, participants will be able to: • summarize the drivers of methicillin-resistant Staphylococcus aureus (MRSA) transmission in healthcare and in the community • debate the pros and cons of various MRSA decolonization strategies • appraise the evidence supporting contact precautions in halting MRSA transmission Objectives: At the conclusion of this session, participants will be able to: • identify key targets for improvement as highlighted in the Surgical Site Infection (SSI) Guideline of the Centers for Disease Control and Prevention’s Healthcare Infection Control Practices Advisory Committee • describe key pieces in the new joint guideline of the American Society of Health-System Pharmacists (ASHP), IDSA, the Surgical Infection Society (SIS), and SHEA, as they relate to rectal, small intestine, and colon surgeries • appraise the current status of public reporting for surgical site infection, including validation Adult ID / Epidemiology and Infection Control / Global ID / Investigative ID / Pediatric ID Pertussis Symposium 2 – 3:30 p.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists Objectives: tbd Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID John F. Enders Lecture Named Lecture 3:45 – 4:30 p.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • summarize the worldwide prevalence of influenza disease • clarify the molecular virology of influenza viruses • highlight challenges in developing an effective influenza vaccine • examine the threat of pandemic influenza, and illustrate possible response(s)
    • IDWEEK 2013TM visit: www.idweek.org24 Friday, October 4, 2013 Adult ID / Global ID / Investigative ID Antimicrobial Stewardship Innovations: New Ideas Across the Country Mini-Symposium 7 – 8:15 a.m. Co-organized with the Society of Infectious Diseases Pharmacists and developed in collaboration with the National Institute of Allergy and Infectious Diseases Audience: academicians, clinicians, fellows, HIV clinicians, HIV specialists, hospital administrators, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, nurses, pharmacists, researchers Objectives: At the conclusion of this session, participants will be able to: • describe novel approaches to implementing antimicrobial stewardship interventions based on local resources • review national initiatives in antimicrobial stewardship and measurement of antimicrobial use Adult ID / Global ID / HIV-STD-TB / Investigative ID A Users’ Guide to Microbiome Analysis Meet-the-Professor Session 7 – 8:15 a.m. Audience: academicians, clinicians, fellows, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • describe how recent advances in the study of the human microbiome have changed our understanding of the role of the indigenous microbiota in health and disease • discuss the nature of microbiome data analysis and how it can be applied to basic, translation, and clinical infectious diseases research • identify how infectious diseases investigators can incorporate microbiome research into their ongoing studies Adult ID / Epidemiology and Infection Control / Investigative ID / Pediatric ID Changes in SSI Reporting in 2014 and 2015, Implications and Practice Change Meet-the-Professor Session 7 – 8:15 a.m. Audience: clinicians, epidemiologists, hospital epidemiologists, infection preventionists, infectious diseases physicians, microbiologists, public health practitioners, researchers Objectives: This session is to provide both a summary of the drivers for change, and the new definitions that will affect Surgical Site Reporting to the Centers for Disease Control and Prevention’s (CDC) National Healthcare Safety Network (NHSN) starting in 2014.  At the conclusion of this session, participants will be able to: • describe the aspects of existing surgical site infection (SSI) definitions that are susceptible to subjective interpretation and result in variations in reported SSI rates in NHSN • outline an algorithm for approaching the detection and reporting of SSI in NHSN starting in 2014 • describe additional variables for NHSN SSI risk adjustment that will be added in 2014 and 2015 • describe the upcoming transition to Current Procedural Terminology (CPT) code-based SSI reporting by 2015 HIV-STD-TB HIV Resistance Testing Meet-the-Professor Session 7 – 8:15 a.m. Audience: clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in-training, public health practitioners, researchers Objectives: At the conclusion of this session, participants will be able to: • discuss viral resistance and resistance testing for HIV-infected patients • apply this knowledge to the selection of antiretroviral therapy Adult ID / Epidemiology and Infection Control / Pediatric ID Infectious Complications of Mechanical Circulatory Support Devices Meet-the-Professor Session 7 – 8:15 a.m. Co-organized with the International Society for Heart and Lung Transplantation Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in-training, microbiologists, nurses, pharmacists Objectives: At the conclusion of this session, participants will be able to: • review the epidemiology of mechanical circulatory support (MCS) device infections • discuss antimicrobial treatment options for driveline-associated infections • describe current infection prevention strategies
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org25 *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org Friday, October 4 continued Adult ID / Epidemiology and Infection Control / Global ID / Investigative ID / Pediatric ID Management of Severe Viral Respiratory Infections Meet-the-Professor Session 7 – 8:15 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • identify current trends in epidemiology of zoonotic respiratory viral threats • employ current treatment guidelines for adults and children hospitalized with influenza • appraise treatment options for severe illness due to other respiratory viruses, including those in immunocompromised hosts • identify antiviral resistance patterns and investigational treatment modalities in influenza Adult ID / Epidemiology and Infection Control / Pediatric ID Pet-Associated Infections and Zoonoses Meet-the-Professor Session 7 – 8:15 a.m. Co-organized with the American Academy of Pediatrics Audience: clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infectious diseases pediatricians, infectious diseases physicians, lab personnel, medical students and residents, members-in-training, nurses, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • identify infection risks from pets in the home • identify infection risks from animals in public settings • review public health implications of infections in home and public settings • highlight infection risks for people with primary and secondary immune deficiencies Epidemiology and Infection Control Preventing Infections Due to Multidrug-Resistant Gram-Negative Rods: Practical Strategies for Acute and Long-Term Care Facilities Meet-the-Professor Session 7 – 8:15 a.m. Audience: clinicians, epidemiologists, fellows, healthcare workers, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases physicians, investigators, medical students and residents, members-in-training, nurses Objectives: At the conclusion of this session, participants will be able to: • discuss the roles of antibiotic stewardship, active surveillance and isolation, cohort nursing, and environmental cleaning in preventing the spread of multidrug-resistant Acinetobacter species and carbapenem-resistant Enterobacteriaceae in acute and long- term care settings • describe regional approaches to control multidrug-resistant Enterobacteriaceae, including U.S. state-based collaboratives, and the contributions of mandatory reporting and administrative measures in the regional control of carbapenem-resistant Enterobacteriaceae in Israel Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Pediatric ID Recognizing Signs and Symptoms of Infection Transmitted Through Transfusion and Transplantation Meet-the-Professor Session 7 – 8:15 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, public health practitioners, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • summarize the current state of organ-transmitted infection, including risk of infection, the most important infectious agents, as well as systems in place to minimize risk • summarize the current state of transfusion-transmitted infection, including risk of infection, the most important infectious agents, as well as systems in place to minimize risk • identify transfusion reactions that can present with fever (including febrile non-hemolytic transfusion reactions, intravascular hemolysis, transfusion-related acute lung injury, and post-transfusion purpura), and review their signs and symptoms, pathophysiology, and work-up
    • IDWEEK 2013TM visit: www.idweek.org26 Friday, October 4 continued Adult ID Wound Care 101 Meet-the-Professor Session 7 – 8:15 a.m. Co-organized with the IDSA Clinical Affairs Committee Audience: clinicians, fellows, healthcare workers, HIV clinicians, hospital administrators, infectious diseases physicians, medical students and residents, members-in-training Objectives: At the conclusion of this session, participants will be able to: • assess type, etiology, and grade or stage of wounds • identify common and uncommon presentations of acute and chronic wounds • apply techniques and skills that can improve wound care patients’ outcomes (hyperbarics, biologic dressings, stem cell therapies, etc.) • identify effective marketing strategies to promote and integrate wound clinics into healthcare systems • use appropriate coding for evaluation and management (E&M) and procedural services rendered in wound care Adult ID / Epidemiology and Infection Control / Global ID / Investigative ID / Pediatric ID Thorny Issues in Infection Control Interactive Session 8:30 – 10 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • respond to case studies that contain difficult problems with infection control and prevention • identify and review the literature that support the recommendations made about approaches to difficult infection control issues • discuss processes and steps to approach controversial or complicated exposures to communicable diseases, outbreaks, or other infection control dilemmas Global ID / Pediatric ID Emerging Infections in Children Symposium 8:30 – 10 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, nurses, public health practitioners, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • describe features of emerging infections • recognize the methods and protocols used for discovery of new pathogens in pediatric patients • cite recent examples of emerging infections in children HIV-STD-TB HIV State-of-the-Art Symposium 8:30 – 10 a.m. Audience: clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases physicians, medical students and residents, members-in-training, researchers Objectives: At the conclusion of this session, participants will be able to: • summarize the state of HIV cure research • apply the latest approaches to managing HIV patients co- infected with hepatitis C to their practice • describe advances in HIV treatment Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID Hot Tropical Topics Symposium 8:30 – 10 a.m. Co-organized with the American Society of Tropical Medicine and Hygiene and the Center for Global Health Policy Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists Objectives: tbd
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org27 Friday, October 4 continued *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org Adult ID Infectious Diseases Diagnostics Update 2013 Symposium 8:30 – 10 a.m. Co-organized with the IDSA Diagnostics Taskforce Report Audience: clinicians, epidemiologists, fellows, hospital epidemiologists, infectious diseases physicians, lab personnel, medical students and residents, members-in-training, microbiologists, nurses Objectives: At the conclusion of this session, participants will be able to: • describe emerging technologies and diagnostic platforms for the diagnosis of common infections such as pneumonia, sexually transmitted infections, and bloodstream infections • discuss the optimal diagnostic tests for specific clinical contexts to support clinical decision-making • demonstrate the benefits and limitations of advanced technologies when interpreting test results Epidemiology and Infection Control New Insights into the Epidemiology and Prevention of Clostridium difficile Infection Symposium 8:30 – 10 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases physicians, medical students and residents, members-in-training, public health practitioners, researchers Objectives: At the conclusion of this session, participants will be able to: • discuss controversies related to determination of routes of Clostridium difficile transmission, including the roles of asymptomatic carriers, community transmission, and accuracy of diagnostic tests • describe the role of environmental cleaning and disinfection in the control of C. difficile transmission in healthcare settings • summarize challenges and opportunities to hospitals associated with public reporting of C. difficile infection rates Adult ID / Global ID / HIV-STD-TB / Pediatric ID Challenging Cases in Tropical Medicine Interactive Session 10:30 a.m. – Noon Co-organized with the American Society of Tropical Medicine and Hygiene Audience: clinicians, HIV clinicians, HIV specialists, infectious diseases pediatricians, infectious diseases physicians, microbiologists, public health practitioners Objectives: tbd Global ID / HIV-STD-TB Integrating Primary and HIV Care in Special Populations Symposium 10:30 a.m. – Noon Co-organized with the Center for Global Health Policy Audience: clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases physicians, researchers Objectives: At the conclusion of this session, participants will be able to: • identify opportunities for integrating primary care into their management of HIV-infected men who have sex with men • discuss and address issues unique to treating adolescents with HIV infection • describe and implement approaches to providing effective HIV care to incarcerated individuals Adult ID / Epidemiology and Infection Control / Global ID / Investigative ID / Pediatric ID Lessons Learned from Fungal Infections Introduced from the Environment: Epidural Steroid Injections or Natural Disasters Symposium 10:30 a.m. – Noon Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists
    • IDWEEK 2013TM visit: www.idweek.org28 Objectives: At the conclusion of this session, participants will be able to: • apply the knowledge of epidemiology to investigation of a new disease • describe diagnostic, clinical, and therapeutic approach in real time and interpretation of neuroradiology findings to management of a new disease • discuss managing an outbreak in real time when no data is available, and recognize the regulatory landscape • review management guidelines for the future Adult ID / Epidemiology and Infection Control / Pediatric ID Management and Prevention of Antibiotic-Resistant Infections in Children Symposium 10:30 a.m. – Noon Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • identify advances in our understanding of the management of methicillen-resistant Staphylococcus aureus infections in children, focusing on novel therapies and the host immune response to infection and strategies for intervention • compare treatment strategies for multidrug-resistant Gram- negative rod infections in children, evaluating the relative risks and benefits of new agents, extended infusion times, and new combinations of anti-infectives • discuss approaches for treatment and prophylaxis of antimicrobial-resistant Candida infections in children Adult ID / Epidemiology and Infection Control / Global ID / Investigative ID / Pediatric ID Transatlantic Milestones in Infection Control: Where are the European Union and the United States Now? Symposium 10:30 a.m. – Noon Co-organized with the European Centre for Disease Prevention and Control Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists Objectives: At the conclusion of this session participants will be able to: • describe the prevalence of key antimicrobial-resistant pathogens and healthcare-associated infections (HAIs) and frequently used antimicrobials, in the United States and the European Union • list the key elements necessary to develop infection control programs in European hospitals • describe and implement necessary actions to prevent importation and spread of antimicrobial-resistant bacteria in hospitals Adult ID / Epidemiology and Infection Control / Global ID / Pediatric ID Vaccines Against Herpes Virus Symposium 10:30 a.m. – Noon Audience: academicians, clinicians, epidemiologists, fellows, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, microbiologists, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • compare and contrast the likelihood of controlling different herpes viruses • recognize the potential for recombination between herpes virus vaccines • summarize how successful vaccines might affect their clinical practice Adult ID / Epidemiology and Infection Control / Global ID / Investigative ID Susceptibility Breakpoints: Controversies, Challenges, and Changes Interactive Session 2 – 3:30 p.m. Audience: academicians, clinicians, epidemiologists, fellows, hospital epidemiologists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • describe the various organizations and agencies that establish susceptibility breakpoints • discuss the controversies and challenges associated with the process of establishing or revising susceptibility breakpoints • utilize susceptibility breakpoints to guide the choice and dosing regimen for antimicrobial agents Friday, October 4 continued
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org29 *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org Friday, October 4 continued Epidemiology and Infection Control / Global ID Decolonization for MDRO Transmission Prevention: Who, What, Where, Why? Symposium 2 – 3:30 p.m. Co-organized with the Center for Global Health Policy Audience: clinicians, epidemiologists, fellows, hospital administrators, hospital epidemiologists, infection preventionists, medical students and residents, members-in-training, microbiologists, nurses, researchers Objectives: At the conclusion of this session, participants will be able to: • summarize the role that the microbiome plays in preventing transmission of multidrug-resistant organisms (MDROs) • debate the pros and cons of various decolonization strategies including their cost-effectiveness • appraise the evidence supporting decolonization in pediatric populations Adult ID / Epidemiology and Infection Control / HIV-STD-TB / Investigative ID Hepatitis C and the Infectious Disease Community Symposium 2 – 3:30 p.m. Co-organized with the IDSA Hepatitis C Taskforce Audience: academicians, clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases physicians, investigators, medical students and residents, members-in-training, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • identify and appraise emerging treatments for hepatitis C virus (HCV) infection including novel direct acting antiviral therapies • apply novel HCV treatments for the treatment of patients with chronic HCV infection • summarize and recommend strategies for monitoring and managing HCV-infected patient during treatment with novel HCV regimens HIV-STD-TB Managing Non-ID Co-Morbidities in HIV-Infected Patients Symposium 2 – 3:30 p.m. Audience: clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases physicians, medical students and residents, members-in-training, researchers Objectives: At the conclusion of this session, participants will be able to: • identify new approaches to addressing central nervous system issues in HIV-infected patients • apply new techniques for preventing and managing cardiovascular disease with HIV patients • describe hot topics in managing osteoporosis and hypogonadism Pediatric ID Pediatric Transplant ID Symposium 2 – 3:30 p.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, lab personnel, medical students and residents, members- in-training, microbiologists, pharmacists Objectives: At the conclusion of this session, participants will be able to: • recognize the respiratory viral infections and invasive fungal infections and their timing after transplantation affecting pediatric transplant patients • describe the mechanism and timing of reactivation of the herpes viruses and their infectious syndromes in pediatric transplant patients • review the available treatment options for the various infections Adult ID Uncommon Presentations of Common Diseases Symposium 2 – 3:30 p.m. Audience: academicians, clinicians, epidemiologists, fellows, health care workers, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, nurses, pharmacists, public health practitioners, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • discuss unusual presentations of infections that commonly present to clinicians in the United States and beyond • discuss aspects of the pathogenesis of rickettsial, cytomegalovirus (cmv), and Plasmodium infections which explains the occurrence of unusual presentations • demonstrate a rational approach to diagnosis and management of unusual manifestations of CMV, malaria, and rickettsial disease
    • IDWEEK 2013TM visit: www.idweek.org30 Epidemiology and Infection Control SHEA Lectureship Named Lecture 3:45 – 4:30 p.m. Audience: epidemiologists, hospital epidemiologists, infection preventionists Objectives: At the end of the presentation, attendees will be able to: • identify prevention progress for at least three types of healthcare- associated infections (HAI) in the past 10 years • describe at least two U.S. national or state policies related to HAI • describe three challenges and opportunities for HAI prevention in the next five years Speaker: Presentation TBD Denise M. Cardo, MD, FIDSA, FSHEA; Centers for Disease Control and Prevention, Atlanta, GA Epidemiology and Infection Control Top Epidemiology and Infection Control Papers of the Year Symposium 4:30 – 5:45 p.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • analyze and critically assess the most important published studies in infection prevention and healthcare epidemiology from the past year • apply effective infection prevention methods based upon the latest published evidence • discuss research gaps and priority areas for future research in healthcare epidemiology and infection prevention Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID Chagas Disease: Diagnosis, Transfusion, Management, Transplantation Symposium 3:45 – 5:45 p.m. Co-organized with the American Society of Tropical Medicine and Hygiene and the Center for Global Health Policy Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, public health practitioners, researchers, scientists Objectives: tbd HIV-STD-TB Clinical Challenges in the Management of STD: Interactive Cases and Panel for the ID and HIV Specialist Symposium 3:45 – 5:45 p.m. Co-organized with the National Network of STD/HIV Prevention Training Centers and the American Sexually Transmitted Diseases Association Audience: clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases physicians, medical students and residents, members-in-training, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • discuss strategies for managing and preventing common sexually transmitted diseases (STDs) in diverse populations of patients • identify data needed to counsel patients more effectively about prevention of common STDs • outline and implement strategies to improve detection and treatment of common STDs • recognize clinical challenges in the management of STDs common in the HIV care setting, especially syphilis and gonorrhea Pediatric ID Hot Topics in Pediatric Infectious Diseases Symposium 3:45 – 5:45 p.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, microbiologists, nurses, pharmacists, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • analyze the year’s important clinical advances and biomedical discoveries that have the potential to impact clinical care • discuss the context of new scientific findings from experts in the field • develop strategies to apply new data to further discovery or clinical practice Friday, October 4 continued
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org31 *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org Saturday, October 5, 2013 Adult ID / Global ID / Investigative ID / Pediatric ID Antimicrobial Pharmacodynamics in Clinical Practice Mini-Symposium 7 – 8:15 a.m. Co-organized with the Society of Infectious Diseases Pharmacists Audience: academicians, clinicians, fellows, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • describe how pharmacokinetics-pharmacodynamics (PK-PD) can be used to select the best antimicrobial agent  • describe how PK-PD can be used to select the best dosing strategy Adult ID / Epidemiology and Infection Control / Pediatric ID Diagnosis of Infection in Transplant Recipients Meet-the-Professor Session 7 – 8:15 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • define new developments in quantitative molecular testing for viruses • identify advances in qualitative molecular testing for infections in transplant recipients, including organism detection and susceptibility testing • recognize Clinical Standard Reference Material available from the National Institute of Standards and Technology, which can help standardize viral load testing in transplant recipients Epidemiology and Infection Control Guidance for Healthcare-Associated Infection Surveillance in Nursing Homes Meet-the-Professor Session 7 – 8:15 a.m. Audience: epidemiologists, hospital epidemiologists, infection preventionists, infectious diseases physicians, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • apply guidance for infection surveillance in nursing homes • describe standardized criteria and methodology for surveillance from the Centers for Disease Control and Prevention • employ new surveillance resources and apply implementation opportunities Adult ID / Epidemiology and Infection Control / Pediatric ID Infection Prevention and Control During Care of Children and Adults with Cystic Fibrosis Meet-the-Professor Session 7 – 8:15 a.m. Audience: clinicians, epidemiologists, fellows, healthcare workers, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, microbiologists, nurses, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • describe new knowledge of pathogens and modes of transmission that have informed the updated infection prevention and control recommendations for care of children and adults with cystic fibrosis • identify new recommendations for infection prevention and control during the care of children and adults with cystic fibrosis patients • apply this knowledge to care processes for children and adults with cystic fibrosis in inpatient and outpatient facilities as well as non-healthcare settings Adult ID / Global ID / Pediatric ID Infections in Pregnancy and their Prevention Meet-the-Professor Session 7 – 8:15 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists
    • IDWEEK 2013TM visit: www.idweek.org32 Saturday, October 5 continued Objectives: At the conclusion of this session, participants will be able to: • recognize the impact of influenza infection and importance of vaccine prevention in pregnant women • discuss the Advisory Committee on Immunization Practice’s recommendations and supporting data on maternal Tdap vaccination for the prevention of both maternal and infant pertussis infection • discuss recent developments in maternal group B Streptococcus (GBS) vaccination for the prevention of fetal and neonatal invasive GBS disease • report on the latest advances in maternal screening and prevention, and infant treatment for congenital cytomegalovirus (CMV) infection Pediatric ID Kawasaki Disease: Where are We Now? Meet-the-Professor Session 7 – 8:15 a.m. Audience: infectious diseases pediatricians Objectives: At the conclusion of this session, participants will be able to: • list the epidemiologic features of Kawasaki Disease (KD) that are highly supportive of an infectious cause • describe recent advances in KD etiology research • cite the standard treatment regimen for uncomplicated KD • name at least three optional treatment for patients who fail to respond to initial treatment • discuss the indications for anti-platelet and systemic anti- coagulation Adult ID / Epidemiology and Infection Control / HIV-STD-TB Leveraging Technology in ID Clinical Care Meet-the-Professor Session 7 – 8:15 a.m. Co-organized with the IDSA Clinical Affairs Committee Audience: clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases physicians, medical students and residents, members-in-training, nurses, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • identify current, cutting-edge technology for use in infection prevention and management • describe the appropriate application of such technology and the benefits it will provide to the ID clinician • discuss the role of teleconferencing and describe how it facilitates better care for patients with HIV and hepatitis C virus (HCV) in rural and underserved areas Adult ID / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID Sinus and Ocular Fungal Infections Meet-the-Professor Session 7 – 8:15 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, nurses, pharmacists, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • differentiate between the clinical manifestations of invasive and non-invasive fungal sinusitis • describe the role of fungi in chronic sinusitis • explain the diagnosis and treatment of fungal keratitis and endophthalmitis Adult ID / Epidemiology and Infection Control / Pediatric ID The ID Physician Who is New to Infection Prevention Meet-the-Professor Session 7 – 8:15 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • describe the functional role of a hospital epidemiologist in relationship to the infection preventionist, the larger quality improvement/patient safety program, and to hospital leadership • provide an overview of the readily available resources for regulation, reporting, and practical infection prevention day-to- day practice • provide insight into common targets for regulatory surveys and how to meet compliance requirements Adult ID / Epidemiology and Infection Control / Investigative ID Virulence Mechanisms as Antimicrobial Targets: Opportunities and Challenges Meet-the-Professor Session 7 – 8:15 a.m. Audience: academicians, clinicians, hospital epidemiologists, infectious diseases physicians, investigators, lab personnel, microbiologists, researchers, scientists
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org33 Saturday, October 5 continued *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org Objectives: At the conclusion of this session, participants will be able to: • review bacterial virulence as an alternative target for next generation antimicrobials, which offer the promise of circumventing the consequences of pathogenesis without directly exerting pressure for pathogen survival in vivo • identify mechanisms of microbial pathogenesis that may be amenable to the development of antivirulence compounds • discuss the opportunities and challenges of designing appropriate clinical trials to evaluate future antivirulence drugs Adult ID / Pediatric ID Interactive Cases in Transplant ID Interactive Session 8:30 – 10 a.m. Co-organized with the Immunocompromised Host Society Audience: academicians, clinicians, fellows, healthcare workers, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in-training, microbiologists, pharmacists Objectives: At the conclusion of this session, participants will be able to: • demonstrate an understanding of the differential diagnosis of fever in a transplant patient • apply the latest diagnostic approaches to evaluation of the transplant patient with infection • recognize new and emerging syndromes causing illness in the transplant patient Adult ID / Global ID / HIV-STD-TB / Pediatric ID Big Beasts of Infectious Disease Symposium 8:30 – 10 a.m. Co-organized with the Center for Global Health Policy Audience: academicians, clinicians, fellows, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in-training, public health practitioners Objectives: At the conclusion of this session, regarding each beast, participants will be able to: • cite current trends in epidemiology of the infection • discuss recent discoveries in the pathogenesis of the disease • appraise current literature on diagnosis • describe effectiveness of current approaches to treatment and prevention Global ID / HIV-STD-TB Complex Medical Management in HIV Care Symposium 8:30 – 10 a.m. Co-organized with the Center for Global Health Policy Audience: clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases physicians, researchers Objectives: At the conclusion of this session, participants will be able to: • identify clinical issues to address with their HIV-infected patients as they age • apply the latest approaches to managing antiretroviral drug- resistance to their practice • describe the latest approaches to managing chronic kidney disease in HIV-infected patients Adult ID / Investigative ID / Pediatric ID Fungi and the Microbiome Symposium 8:30 – 10 a.m. Audience: academicians, clinicians, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, microbiologists, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • explain how fungi interact with bacteria in the gastrointestinal tract • explain how interactions between fungi and bacteria affect microbial virulence • explain how perturbations in the microbiome affect microbial virulence Adult ID / Global ID / Investigative ID New and Near Available Anti-Infective Therapy Symposium 8:30 – 10 a.m. Audience: academicians, clinicians, fellows, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • describe newly available antibacterial, antiparasitic, and antifungal agents • describe those agents that will be available in the near future
    • IDWEEK 2013TM visit: www.idweek.org34 Adult ID / Epidemiology and Infection Control / Global ID / Investigative ID / Pediatric ID Pneumococcal Disease and Prevention Symposium 8:30 – 10 a.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • identify the use and impact of pneumococcal vaccines in children and adults • identify the impact of pneumococcal vaccines on the selection of circulating serotypes • apply this knowledge to recommend appropriate vaccines for specific groups Adult ID / Epidemiology and Infection Control / Investigative ID Vancomycin-Resistant Enterococcus Symposium 8:30 – 10 a.m. Audience: academicians, clinicians, epidemiologists, fellows, hospital epidemiologists, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, microbiologists, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • summarize results of recent enterococcal genomic analyses and their implications • discuss daptomycin-resistance in enterococci and implications • describe the effect of antibiotics on vancomycin-resistant enterococci colonization of the gastrointestinal tract Epidemiology and Infection Control / Investigative ID Advanced Design and Analysis of Intervention Studies for HAI Prevention Symposium 10:30 a.m. – Noon Audience: clinicians, epidemiologists, fellows, health care workers, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, members-in- training, nurses, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • describe methods to enhance the strength of evidence in quasi- experimental studies • compare and contrast the strengths and weaknesses of efficacy vs. effectiveness studies • describe methods to improve data synthesis Epidemiology and Infection Control / Pediatric ID Clostridium difficile Infection in Children Symposium 10:30 a.m. – Noon Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in-training Objectives: At the conclusion of this session, participants will be able to: • discuss the changing epidemiology of Clostridium difficile infections in children • identify key bacterial and host factors important for the pathogenesis of C. difficile infections • evaluate and implement the options for treatment of routine and recalcitrant C. difficile infections in children Adult ID / HIV-STD-TB Hot Topics in STIs Symposium 10:30 a.m. – Noon Co-organized with the American Sexually Transmitted Diseases Association Audience: academicians, clinicians, fellows, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in-training, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • summarize new directions in treatment and prevention of sexually transmitted pathogens • describe the utility of nucleic acid amplification test for detecting rectal and pharyngeal gonococcal, and chlamydial infections • review current evidence supporting the pathogenic nature of Mycoplasma genitalium and approaches to treatment • discuss controversies surrounding the determination of need for lumbar puncture to diagnose neurosyphilis, and approaches to treatment and follow-up Saturday, October 5 continued
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org35 *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org Saturday, October 5 continued Adult ID / HIV-STD-TB Management of the HIV-Transplant Patient Symposium 10:30 a.m. – Noon Co-organized with the Society of Infectious Diseases Pharmacists Audience: academicians, clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases physicians, investigators, nurses, pharmacists, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • list the majority drug interactions between HIV and transplant medications • describe the currently accepted listing criteria for HIV-positive patients to undergo solid-organ transplantation • describe the outcomes of hematopoietic cell transplantation in HIV-infected patients Epidemiology and Infection Control Should Hospital HAI Prevention Policies Translate to Nursing Homes? Symposium 10:30 a.m. – Noon Audience: epidemiologists, hospital epidemiologists, infection preventionists, infectious diseases physicians, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • apply practical infection control and prevention policies that translate between acute care and long-term care settings • compare and contrast the pros and cons surrounding contact precautions in nursing homes • compare and contrast the pros and cons surrounding active surveillance in nursing homes Adult ID / Epidemiology and Infection Control / Global ID / Pediatric ID Update on Emerging Vector-Borne Diseases in the United States Symposium 10:30 a.m. – Noon Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, infectious diseases pediatricians, infectious diseases physicians, medical students and residents, members-in- training, microbiologists, nurses, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • describe the recent changes in epidemiology and/or clinical presentation of West Nile virus in the United States • recognize recently discovered emerging tick-borne diseases in the United States Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID Challenging Cases in ID Interactive Session 2 – 3:30 p.m. Audience: academicians, clinicians, infectious diseases physicians, medical students and residents, members-in-training, pharmacists Objectives: It is assumed that participants know or are familiar with basic concepts in the recognition, pathogenesis, differential diagnosis, and management of infectious diseases. These skills will be challenged through a series of “unknown” case presentations in which the audience participants will be able to compare their case analyses to those of a panel of experts. At the conclusion of this session, participants, through observation and discussion, will be able to apply new skills in the approach to the analysis of infectious diseases syndromes as well as development of a differential diagnosis and a management approach for infectious diseases. Adult ID / Investigative ID Biofilm Biology in Infectious Diseases Symposium 2 – 3:30 p.m. Audience: academicians, clinicians, epidemiologists, fellows, health care workers, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • discuss the timing and regulation of antimicrobial tolerance in bacterial biofilms • predict host environments where bacterial surface colonization is likely to occur and apply strategies to limit colonization • discuss recently identified natural products that disassemble biofilms and efforts to develop synthetic analogues as biofilm dispersing agents
    • IDWEEK 2013TM visit: www.idweek.org36 Adult ID / Global ID / Pediatric ID Choosing a Career in Infectious Diseases Symposium 2 – 3:30 p.m. Co-organized with the IDSA ID Training Program Directors’ Committee Audience: fellows, medical students and residents, members-in- training Objectives: At the conclusion of this session, attendees will be able to: • review job prospects for medical trainees based on recent job surveys conducted among graduating infectious diseases trainees • identify career paths and opportunities within the field of infectious diseases HIV-STD-TB Developments in Diagnostics and Treatment for Tuberculosis Symposium 2 – 3:30 p.m. Co-organized with the Center for Global Health Policy Audience: clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, public health practitioners, researchers Objectives: At the conclusion of this session, participants will be able to: • discuss the latest advances in new and recently approved drugs for treatment of tuberculosis • identify new approaches to treating complex tuberculosis cases • describe novel tools to diagnose tuberculosis and how to use them in clinical practice Epidemiology and Infection Control Hand Hygiene—Keeping Hands Clean Symposium 2 – 3:30 p.m. Audience: clinicians, epidemiologists, fellows, hospital administrators, hospital epidemiologists, infection preventionists, microbiologists, nurses, researchers Objectives: At the conclusion of this session, participants will be able to: • identify ethical issues surrounding hand hygiene compliance and how they might be leveraged to improve compliance • recall the role that environmental cleaning plays in hand hygiene contamination and the transmission of antimicrobial-resistant pathogens • list advantages and disadvantages of novel hand hygiene technologies HIV-STD-TB Healthcare Reform and the Future of HIV Care Symposium 2 – 3:30 p.m. Audience: clinicians, fellows, HIV clinicians, HIV specialists, infectious diseases physicians, medical students and residents, members-in-training, public health practitioners Objectives: At the conclusion of this session, participants will be able to: • prepare for providing HIV care in a new healthcare financing environment • identify opportunities to improve HIV care using electronic technology • describe the role of generic antiretrovirals in HIV treatment in the United States Adult ID / Epidemiology and Infection Control / Pediatric ID Infection Prevention Beyond Hospital Walls Symposium 2 – 3:30 p.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, medical students and residents, members-in-training, nurses, researchers, scientists Objectives: At the conclusion of this session, participants will be able to: • understand health system approaches to prevention practices and policies in hemodialysis centers • provide practical guidance for infection prevention in high risk cancer populations • describe issues and implement solutions for preventing infections in medical residential facilities Saturday, October 5 continued
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org37 *Speaker information and updates to the program are available on the Interactive Program Planner at www.idweek.org Saturday, October 5 continued Adult ID / Global ID / HIV-STD-TB / Pediatric ID New Developments in Tuberculosis Symposium 2 – 3:30 p.m. Co-organized with the Center for Global Health Policy Audience: HIV clinicians, HIV specialists, infectious diseases pediatricians Objectives: tbd Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID Joseph E. Smadel Lecture Named Lecture 3:45 – 4:30 p.m. Co-organized with the Center for Global Health Policy Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • discuss the remarkable development of a myriad of agents that allow normal life span in people with HIV infection—literally changing the prognosis from certain death to survival • describe the use of some of these agents—based on pharmacological properties—for concomitant prevention of transmission, and implementation of this approach • understand the race to cure HIV, including implications of early treatment, development of new agents, and pharmaco- immunology as the way forward Speaker: The Evolution of Antiretroviral Agents: From Survival to Prevention, to Cure Myron S. Cohen, MD, FIDSA; University of North Carolina, Chapel Hill, NC Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID Maxwell Finland Lecture Named Lecture 5 – 5:45 p.m. Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • describe the historical and current approaches to prevention of healthcare-associated infections • describe regulatory, cultural, and governmental influences driving changes in healthcare epidemiology and infection prevention • identify the challenges and opportunities to improve patient safety and quality, and reduce the risk of healthcare-associated infections in the future Speaker: Successes and Challenges in Preventing Healthcare-Associated Infections Victoria J. Fraser, MD, FIDSA, FSHEA; Washington University School of Medicine, St. Louis, MO
    • IDWEEK 2013TM visit: www.idweek.org38 • identify at least two other sexually transmitted pathogens in which resistance to standard antimicrobial therapy has been identified • idenfity the patterns of emerging malaria resistance and what’s happening with emerging artemesinin resistance in Southeast Asia • explain how practitioners should devise therapy for travelers with malaria from different regions of the world • recognize what new malaria drugs are under development now and may replace artemesinin combination therapy (ACT) if resistance becomes widespread Speakers: Malaria Drug Resistance: Caught in the ACT Wesley Van Voorhis, MD, PhD, FIDSA; University of Washington, Seattle, WA Antimicrobial Resistance in Sexually Transmitted Infections: We are Facing the Untreatable Jeanne M. Marrazzo, MD, MPH, FIDSA; University of Washington, Harborview Medical Center, Seattle, WA The Future of Antibiotics and Resistance Brad Spellberg, MD, FIDSA; Harbor-UCLA Medical Center, Torrance, CA Progress and Challenges in Diagnosis and Treatment of Drug- Resistant TB Sarita Shah, MD, MPH; International Research and Program Branch, Centers for Disease Control and Prevention, Atlanta, GA Sunday, October 6, 2013 Adult ID / Epidemiology and Infection Control / Global ID / HIV-STD-TB / Investigative ID / Pediatric ID Closing Plenary Session: Global Resistance Plenary Session 8 – 10 a.m. Co-organized with the Center for Global Health Policy Audience: academicians, clinicians, epidemiologists, fellows, healthcare workers, HIV clinicians, HIV specialists, hospital administrators, hospital epidemiologists, infection preventionists, infectious diseases pediatricians, infectious diseases physicians, investigators, lab personnel, medical students and residents, members-in-training, microbiologists, nurses, pharmacists, public health practitioners, researchers, scientists, vaccinologists Objectives: At the conclusion of this session, participants will be able to: • review the priority areas of un-met need to address antibiotic- resistant infections • identify the barriers and solutions to new technology development • describe policy recommendations to facilitate prevention and treatment of resistant infections • discuss major developments in the evolution of antibiotic- resistant gonorrhea in the last two years • describe the rationale for treatment with parenteral cephalosporins for uncomplicated gonorrhea
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org39 American Academy of Pediatrics Challenging Cases in Pediatric Infectious Diseases Interactive Session (pg. 15) Pet-Associated Infections and Zoonoses Meet-the-Professor (pg. 25) American Sexually Transmitted Diseases Association Clinical Challenges in the Management of STD: Interactive Cases and Panel for the ID and HIV Specialist Symposium (pg. 30) Hot Topics in STIs Symposium (pg. 34) American Society of Tropical Medicine and Hygiene Hot Tropical Topics Symposium (pg. 26) Challenging Cases in Tropical Medicine (pg. 27) Chagas Disease: Diagnosis, Transfusion, Management, Transplantation Symposium (pg. 30) British Columbia Centre for Disease Control Genomic Tools for Personalized Infectious Diseases Management and Outbreak Investigations Symposium (pg. 20) Center for Global Health Policy TB Workshop Pre-meeting Workshop (pg. 14) Influenza Symposium (pg. 15) What’s Hot in ID and HIV Symposium (pg. 16) Clinical Controversies Interactive Session (pg. 19) A Reinterpretation of Borders: Lessons Learned from Mycobacterium tuberculosis Pathogenesis Symposium (pg. 20) Polio Eradication Symposium (pg. 21) Advances in HIV Prevention Symposium (pg. 22) Global Viral Threats Symposium (pg. 22) Media, Social Media, and Open Access: Communicating the Science of Infectious Disease Symposium (pg. 22) Hot Tropical Topics Symposium (pg. 26) Integrating Primary and HIV Care in Special Populations Symposium (pg. 27) Decolonization for MDRO Transmission Prevention: Who, What, Where, Why? Symposium (pg. 29) Chagas Disease: Diagnosis, Transfusion, Management, Transplantation Symposium (pg. 30) Big Beasts of Infectious Disease Symposium (pg. 33) Complex Medical Management in HIV Care Symposium (pg. 33) Developments in Diagnostics and Treatment for Tuberculosis Symposium (pg. 36) New Developments in Tuberculosis Symposium (pg. 37) Named Lecture: Joseph E. Smadel Lecture (pg. 37) Closing Plenary Session: Global Resistance (pg. 38) European Centre for Disease Prevention and Control Transatlantic Milestones in Infection Control: Where are the European Union and the United States Now? Symposium (pg. 28) European Society of Clinical Microbiology and Infectious Diseases New Insights into the Microbiology and Epidemiology of Multidrug-Resistant Gram-Negative Bacteria Symposium (pg. 15) Preventing Infection in Healthcare Personnel Symposium (pg. 20) International Immunocompromised Host Society Top 10 Papers in Transplant Infectious Disease Meet-the-Professor (pg. 18) Interactive Cases in Transplant ID Interactive Session (pg. 33) International Society for Heart and Lung Transplantation Infectious Complications of Mechanical Circulatory Support Devices Meet-the-Professor (pg. 24) National Institute of Allergy and Infectious Diseases Meaningful Antimicrobial Stewardship Outcomes Symposium (pg. 19) Antimicrobial Stewardship Innovations: New Ideas Across the Country Mini-Symposium (pg. 24) National Network of STD/HIV Prevention Training Centers Clinical Challenges in the Management of STD: Interactive Cases and Panel for the ID and HIV Specialist Symposium (pg. 30) ALLIED SOCIETIES
    • IDWEEK 2013TM visit: www.idweek.org40 Society of Infectious Diseases Pharmacists Best Practices in Antimicrobial Stewardship Programs Pre-meeting Workshop (pg. 13) Rapid Diagnostics for Infection Prevention and Antimicrobial Stewardship Meet-the-Professor (pg. 18) Meaningful Antimicrobial Stewardship Outcomes Symposium (pg. 19) Antimicrobial Stewardship Innovations: New Ideas Across the Country Mini-Symposium (pg. 24) Antimicrobial Pharmacodynamics in Clinical Practice Mini- Symposium (pg. 31) Management of the HIV-Transplant Patient Symposium (pg. 35) Wake Forest University School of Medicine IDSA Maintenance of Certification Workshop: Self-Evaluation of Medical Knowledge Modules: General Infectious Diseases 2011 (Updated February 2013), Infections in the Non-HIV Immunocompromised Host Pre-meeting Workshop (pg. 13) IDSA Maintenance of Certification: Self-Evaluation of Medical Knowledge Modules: HIV 2013 and Hepatitis C Pre-meeting Workshop (pg. 14) ALLIED SOCIETIES continued The American Society of Tropical Medicine and Hygiene (ASTMH) will hold an Intensive Update Course in Clinical Tropical Medicine and Travelers’ Health on September 30 to October 1, 2013 at the Marines’ Memorial Club & Hotel in San Francisco, immediately preceding IDWeek™. This course provides a broad overview of core topics in clinical tropical medicine and travelers’ health. Presented in a two-day condensed format, it is an excellent review for physicians and all other health care providers working in tropical medicine or travelers’ health. For course details, visit www.astmh.org, email Buffy American Society of Tropical Medicine and Hygiene Intensive Update Course in Clinical Tropical Medicine and Travelers’ Health Finn, Member Services Administrator at bfinn@astmh.org or contact ASTMH, 111 Deer Lake Road, Suite 100, Deerfield, IL 60015, phone (847) 480-9592, fax (847) 480-9282. Hotel accommodations can be made directly with guest services at the Marines’ Memorial Club & Hotel, 609 Sutter Street, San Francisco, California, 94102 by calling (415) 673-6672 x 0 or by calling toll-free at (800) 562-7463. Mention that you are attending the ASTMH Intensive Update Course to receive the special rate of $209 single/double, plus applicable taxes.
    • San Francisco, CA • October 2 - 6, 2013 visit: www.idweek.org41 Chairs: Robert C. Read, MD, FIDSA, IDWeek Chair, IDSA Southampton General Hospital, Southampton, England Larry K. Pickering, MD, FIDSA, IDWeek Vice-Chair, IDSA Centers for Disease Control and Prevention, Atlanta, GA Scott K. Fridkin, MD, IDWeek Chair, SHEA Centers for Disease Control and Prevention, Atlanta, GA Mary K. Hayden, MD, FIDSA, FSHEA, IDWeek Vice-Chair, SHEA Rush University Medical Center, Chicago, IL Joel E. Gallant, MD, MPH, FIDSA, IDWeek Chair, HIVMA Johns Hopkins University School of Medicine, Baltimore, MD Rochelle Walensky, MD, MPH, FIDSA, IDWeek Vice-Chair, HIVMA Massachusetts General Hospital, Boston, MA Penelope H. Dennehy, MD, FIDSA, IDWeek Chair, PIDS Brown University, Providence, RI Tina Q. Tan, MD, FIDSA, IDWeek Vice-Chair, PIDS Northwestern University, Chicago, IL Members: David R. Andes, MD, University of Wisconsin Hospital, Madison, WI Johan S. Bakken, MD, PhD, FIDSA, Infectious Disease Associates and St. Luke’s Hospital, Duluth, MN Constance A. Benson, MD, FIDSA, University of California, San Diego, Antiviral Research Center, San Diego, CA Sujata M. Bhavnani, PharmD, Institute for Clinical Pharmacodynamics, Latham, NY Gail A. Bolan, MD, Centers for Diseases Control and Prevention, Atlanta, GA Ronald De Groot, MD, PhD, Radboud University Nijmegen, Nijmegen Netherlands Daniel J. Diekema, MD, FIDSA, FSHEA, University of Iowa, Carver College of Medicine, Iowa City, IA Vance G. Fowler, Jr., MD, Duke University Medical Center, Chapel Hill, NC Bruce Gellin, MD, MPH, FIDSA, Department of Health and Human Services, Washington, DC Paul D. Griffiths, MD, University College London, London, United Kingdom Susan Hadley, MD, FIDSA, Tufts Medical Center, Boston, MA Kimberly E. Hanson, MD, University of Utah, Salt Lake City, UT IDWeek 2013 Program Committee Susan S. Huang, MD, FIDSA, University of California, Irvine School of Medicine, Orange, CA James M. Hughes, MD, FIDSA, Emory University, Atlanta, GA W. Charlie Huskins, MD, MSc, FSHEA, Mayo Clinic, Rochester, MN Keith P. Klugman, MD, PhD, FIDSA, Emory University, Atlanta, GA Michael G. Kurilla, MD, PhD, National Institute of Allergy and Infectious Diseases, Bethesda, MD Abhijit (Ajit) P. Limaye, MD, FIDSA, University of Washington, Seattle, WA Daniel P. McQuillen, MD, FIDSA, Lahey Clinic Center for Infectious Diseases, Burlington, MA Eleftherios Mylonakis, MD, FIDSA, Rhode Island Hospital, Providence, RI Joshua D. Nosanchuk, MD, FIDSA, Albert Einstein College of Medicine, Bronx, NY Eric Pamer, MD, FIDSA, Memorial Sloan-Kettering Cancer Center, New York, NY Robin Patel, MD, FIDSA, Mayo Clinic, Rochester, MN Andrew T. Pavia, MD, FIDSA, FSHEA, University of Utah, Salt Lake City, UT Eli N. Perencevich, MD, FIDSA, FSHEA, University of Iowa, Carver College of Medicine, Iowa City, IA Trish M. Perl, MD, MSc, FIDSA, FSHEA, The Johns Hopkins Medical Institutions, Baltimore, MD Cathy A. Petti, MD, HealthSpring Global Inc., Albuquerque, NM Liise-anne Pirofski, MD, FIDSA, Albert Einstein College of Medicine, Bronx, NY Kent A. Sepkowitz, MD, FIDSA, FSHEA, Memorial Sloan- Kettering Cancer Center, New York, NY Costi D. Sifri, MD, University of Virginia Medical Center, Charlottesville, VA Mark Sulkowski, MD, Johns Hopkins Medical Institute, Baltimore, MD Joseph M. Vinetz, MD, FIDSA, University of California, San Diego, La Jolla, CA Anna Wald, MD, MPH, FIDSA, University of Washington, Seattle, WA David A. Relman, MD, FIDSA, IDSA President, Ex-officio, Stanford University School of Medicine, Palo Alto, CA Barbara E. Murray, MD, FIDSA, IDSA President-Elect, Ex- officio, University of Texas Health Science Center, Houston, TX